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Abstract
Mathematical disease modeling has long operated under the assumption that any one
infectious disease is caused by one transmissible pathogen. This paradigm has been
useful in simplifying the biological reality of epidemics and has allowed the modeling
community to focus on the complexity of other factors such as contact structure and
interventions. However, there is an increasing amount of evidence that the strain
diversity of pathogens, and their interplay with the host immune system, can play a
large role in shaping the dynamics of epidemics.
This body of work first explores the role of strain-transcending immunity in mathematical disease models, and how genotype networks may be used to explore the
evolution of multistrain pathogens. A model is introduced to follow multistrain epidemics with an underlying genotype network. Consequently, the genotype network
structure of the antigenic hemagglutinin protein of influenza A (H3N2) is analyzed,
suggesting the important role of strain-transcending immunity in the evolution of the
virus.
The unique structure of the influenza genotype network is then explored with
age-weighted preferential attachment models, utilizing approximate Bayesian computation of the network growth mechanisms. Finally, multistrain vaccination strategies
are identified through the application of a genetic algorithm towards minimization of
super-critical strains.
Altogether, we show the impact of genotype networks on multistrain disease modeling, explore the role of empirical genotype network structure, and identify applications that include network generative models and vaccine strain selection.
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Chapter 0
Introduction
Mathematical disease modeling often operates under the assumption that a single
disease is caused by a single pathogen spreading among a population. This paradigm
has been useful in simplifying the biological reality of contagions and has allowed the
community to focus on the complexity of other factors such as population structure.
However, we have long since known of strain diversity within pathogens, and there is
an increasing amount of evidence that the diversity of strains and their interplay with
the host immune system can play a large role in shaping the dynamics of epidemics [1,
2, 3, 4]. Surveillance efforts have provided unprecedented sequence data for pathogens
such as seasonal influenza, enabling a greater understanding of genetic diversity [5].
The increasing availability of genomic data may be used to understand the evolution
of the pathogen, and inform epidemic models that incorporate multiple strains and
the relationships between them.
The work presented within this document addresses the need to consider mathematical disease models beyond the “one disease, one pathogen” paradigm, regarding:
(i) the dynamics within multistrain mathematical epidemic models, (ii) the struc1

ture of influenza A genotype networks and its exploration of genotype space, (iii) an
understanding of the generative processes that may determine the structure of viral genotype networks, and (iv) strain-specific considerations for multivalent vaccine
selection. We will show that modeling multiple strains is a task that must balance
biological realism while maintaining computational tractability. Central to this exploration is the use of the genotype network, a structure that concisely stores strains
and the genetic relationships between them. Genotype networks are central to this
body of work, with applications in multistrain models, the evolution of influenza A
(H3N2), network generative models, and multivalent vaccination strategies.
The following themes are addressed in this thesis. First, we consider the dynamics of epidemics with multiple interacting strains and an underlying genotype
network structure (Chapter 1). Particular attention is given towards the endemic
state, phase transitions, cyclicity, and localization of infections by strain. This investigation explains the need to consider multiple strains to better understand the
dynamics of multistrain pathogens. In Chapter 2 we explore the structure of genotype
networks used in the model presented in Chapter 1. Influenza A (H3N2) is used as
the model pathogen to leverage the significant quantity of sequence data made available through increased surveillance efforts of the past two decades. The structure of
the genotype network is then interpreted in the context of evolution and the effects
of cross-protective immunity. A theoretical model of genotype network generation
is then explored in Chapter 3 utilizing age-weighted preferential attachment. This
exploration relies on approximate Bayesian computation, whose application towards
network generative methods is explained more generally. This chapter explores the
role of node age within network formation and how it might explain the emergence
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of strains within genotype networks. Finally, a method for multivalent vaccine strain
selection is developed with consideration for cross-protective immunity in Chapter 4.
A genetic algorithm is implemented to provide maximum immune protection across
a genotype network under the specified conditions, offering a theoretical vaccination
strategy for multiple strains. Together, these themes address the greater need for
consideration of multiple strains in mathematical disease modeling.

0.1

Multistrain epidemic models

The mathematical modeling of diseases has been used to influence public health policy, understand the ecology and evolution of pathogens and their hosts, and further
the methodology of mathematics, statistics, and more recently, of network science.
The construction of an appropriate model can be used to predict disease incidence,
determine the effects of climate and animal reservoir population size on risk for human infection, and understand the antigenic variation between strains of a disease.
With the careful definition of assumptions, specific processes may be brought to light
in an attempt to understand the interaction between humans and pathogens.
The first documented example of mathematical modeling of the spread of disease dates to 1766, when Bernoulli constructed a simple model to justify widespread
inoculation against smallpox [6]. This model explored the gains in life expectancy
if smallpox were to be eliminated as a cause of death, using differential equations
to describe the rate of change for persons who either had not had smallpox or had
recovered at a given age [7]. This compartmentalization of persons based on their
infection state proved to be an enduring method of organizing a population relative
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to some disease.
Early advances on compartmental disease modeling took advantage of the law of
mass action, resulting in simple deterministic models. From 1927 to 1933 Kermack
and McKendrick developed what is referred to as the SIR and SIRS models, in which
a population is divided into suspectible, infectious, or recovered persons, with differential equations governing the rate of flow between compartments [8, 9, 10]. These
models have since become the framework of numerous stochastic and deterministic
models [11, 12]. An important caveat to these models is their simplicity, with the
often fragile assumption of mass action, described as the homogeneous mixing of persons within a population. This implies that each person is equally likely to come into
contact with any other, without consideration for contact structure. Varying degrees
of correction exist for heterogeneous mixing, such as pair approximations to account
for clustering effects, to offer an intermediate level of model complexity between mass
action and agent-based models.
The assumptions of mass action models can be improved upon with network epidemiology. A contact network may be introduced to allow for heterogeneity in possible transmission routes, allowing for more realistic spread in human populations than
mass action models may allow [13]. Networks can account for heterogeneity at more
than one level of disease transmission — we similarly use networks at a different level,
that of the viral genotype, to account for different strains of the same pathogen.
Chapter 1 focuses on a deterministic compartmental model of disease dynamics
with an underlying genotype network, enabling a straightforward analysis of the endemic state. The endemic state is the number of infections maintained indefinitely
in a population under a set of conditions without perturbation. Although disease
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transmission is in principle a stochastic process, deterministic modeling provides a
versatile framework for studying the endemic state [14]. The effects of demographics
on endemic states is in general well understood, but there is a noted need to study
the effects of waning immunity (immunity loss at the individual level) on the endemic
state, which is of relevance to the cross-protective immunity noted in some pathogens
[14, 15].
Accounting for multiple strains within a model may address numerous challenges
regarding model realism. For instance, an effective waning immunity may exist as
novel strains emerge with different antigenic properties, rendering immunity acquired
towards past strains less effective. Allowing for multiple strains within a model allows
for a wide variety of modeling choices, which together must balance biological realism
with mathematical and computational tractability [16].
Multistrain models are inherently high-dimensional and must take advantage of
reductions via symmetry to reduce complexity. A history-based compartmental model
with n strains, in which all past infections of a person would be accounted for, contains 2n combinations of infections a person could have as their history [1]. With the
number of differential equations governing this model proportional to 2n , simplifications must occur to investigate situations in which a practical number of strains are
considered.
Of importance to multistrain models and their reduction is the antigenic distance
between strains. The human immune system recognizes pathogens by some part of
their molecular structure, known as an antigen, to which an antibody may be produced to neutralize the pathogen. The antigenic properties may differ between strains,
affecting the body’s ability to respond effectively given a novel structure. Antigenic
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differences may develop gradually through site mutation, known as antigenic drift, or
suddenly such as through genetic reassortment, known as antigenic shift [17]. The
former is responsible for continual updates to seasonal influenza vaccines, to keep up
with the antigenic features of circulating and not past strains [? ]. The latter may
produce more extreme antigenic changes, which has been responsible for numerous
influenza pandemics in the last century [18].
Modeling multistrain pathogens with consideration for antigenic properties requires the inclusion of cross-protective effects, in which the immunity acquired towards
one strain offers partial protection towards another strain based on their antigenic
similarity. Cross-protection is seen within orthopoxviruses, seasonal influenza subtypes, ebolavirus species, and other pathogens [19, 20, 21]. In general, more similar
strains will have greater cross-protective effects, as with influenza A [22]. However,
cross-protective immunity is not necessarily a monotonically decreasing function of
antigenic distance. Antibody-dependent enhancement has been observed in dengue
viruses, in which a past infection may in fact increase the risk of severe infection
[23]. Regardless, approximations may be made through antigenic distance. Instead
of a unique cross-protective relationship for all combinations of strains, the relationship may be defined as a function of the antigenic distance. This results in antigenic
neighborhoods of different antigenic distances from a strain [24]. This simplifying assumption of symmetry reduces model complexity from O(2n ) to O(n ú (m + 1)) when
up to m neighborhoods of antigenic distance are considered. Given that influenza A

will be the pathogen of interest for all chapters, cross-protective immune effects will
be modeled by an exponentially decaying function of genetic distance, which may be
used as an approximation of antigenic distance [22].
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Multistrain models must also consider strain mutation. Although strain mutation is an inherently stochastic process, we choose a deterministic model in this body
of work, given the focus on short-term evolutionary trajectory and infection localization in genotype space that may result from cross-protective effects. High strain
diversity is to be expected in deterministic models of mutation, given the absence of
extinction events removing strains from circulation [25]. As such, the localization of
infections within genotype space will be commented on, rather than the presence or
absence of particular strains. However, it is possible to incorporate discrete stochastic strain emergence and extinction within the system of equations for a multistrain
compartmental model [26]. Regardless of implementation, mutations occur frequently
in many pathogens, with RNA viruses such as influenza having significant mutation
rates [27, 28]. This necessitates the inclusion of mutation for multistrain models,
allowing for evolution from one strain to another. Although mutation allows for the
emergence of novel strains, the success of strains will depend on a fitness landscape
influenced by numerous factors that include host population immunity.

0.2

Viral genotype networks

Genotype networks are efficient structures used to relate strains through their genetic similarity and plausible evolutionary pathways. A network, also referred to as
a graph, consists of nodes that represent objects, and edges connecting nodes if some
relationship exists between them. In a genotype network, the nodes are strains defined by their unique genetic sequences, with edges existing between strains whose
sequences differ by just one nucleic acid or whose proteins differ by one amino acid,
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indicating a plausible mutation pathway [29]. Genotype networks may be considered
complementary to phylogenetic trees. Relative to phylogenetic trees, genotype networks allow for cycles indicative of convergent evolution at the cost of having to infer
ancestor-descendant directionality.
Selecting an appropriate sequence from the genome of a pathogen, for purposes
of defining a strain, will maximize the influence of a mutation on the antigenic properties of the pathogen. Immunoassays are able to concisely describe the antigenic
relationship between two strains, namely how well antibodies developed against one
strain protects against the another strain. However, immunoassays require all relationships between a set of virus samples to be sampled, which may be unavailable.
Instead, identification of a highly antigenic region of a pathogen, as well as epitope
regions where an antibody binds to an antigen, can identify genomic regions that are
predictive of antigenic properties [30].
A genotype network has previously been defined for influenza A (H3N2) based on
the sequence of its surface protein hemagglutinin (HA) [29]. HA is a highly antigenic
region of the influenza virion, whose function is to bind the virion to the surface of
a host cell and then facilitate the entry of the viral genome for replication within
the host cell [31] . HA contains numerous epitopes, making it an important target
for the human immune system. As a result, positive Darwinian selection has been
observed with ever-changing HA sequences, evolving away from past strains that have
influenced the immune profile of the population [2? ].
In 2014 Wagner constructed a genotype network for HA of influenza A (H3N2),
a subtype of seasonal influenza A that has circulated widely since 2010 alongside
subtype H1N1 [29]. This network was shown to have cycles that indicated the pres-
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ence of multiple mutations at the same site, as well as convergent evolution. The
network featured distinct communities and a tree-like structure, with regions of low
connectivity spanning the genotype space between high-degree hubs that had numerous genetic neighbors. The presence of strong community structure agrees with that
of antigenic clusters found using reduced dimensions of HA inhibition assays and the
corresponding phylogenetic trees [32]. The degree of a strain indicated the number of
sampled genetic neighbors it had within a distance of one amino acid that could be
spanned by a single amino acid substitution. The degree distribution of the network
was characteristically heavy-tailed, indicating a high prevalence of strains with few
genetic neighbors and a low prevalence of strains with many neighbors. This reflects
the trunk-like nature of the phylogenetic trees of seasonal influenza, with periods of
strain growth followed by extinction in a forward movement through genotype space,
away from past strains [33, 2].
Seasonal influenza surveillance has increased dramatically since 2008, warranting
a network analysis of influenza sequences obtained beyond the samples from 2002 to
2007 used by Wagner [29, 34, 35]. Among 35 countries partnering with the CDC,
the number of influenza specimens processed per year increased from approximately
100,000 or fewer from 2004 to 2008, to more than 300,000 per year from 2009 to 2013
[34]. Increased surveillance allows for greater coverage of circulating strains, which
benefits genotype networks in particular due to the precision required at the level of
one amino acid to construct the network. Increased surveillance will produce a less
sparse and fragmented genotype network, better capturing the evolutionary pathways
between strains.
Genotype networks may be used with multistrain models due to their ability to
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capture mutation pathways. Edges within a genotype network indicate a plausible mutation pathway between two strains that may be bridged by just one amino
acid substitution [29]. A genotype network consists of the region of genotype space
that a pathogen has been observed to explore, providing both known strains and the
plausible mutation pathways between them. As such a genotype network provides
a set of strains for a multistrain model that may be either model networks or networks informed by real-world observations. Multistrain models informed by genotype
networks thus offer a bridge between existing literature on dynamics of multistrain
models and the wealth of genomic data available for multistrain pathogens such as
seasonal influenza.

0.3

Network generative models

Real-world networks such as genotype networks often fall into distinctive categories
based on their topologies, which may be explained through relevant network generative models. Networks are complex structures, with information contained in their
topology that may be extracted by understanding the process by which the network
formed. Network generative models are tools used to construct networks, explain
features of existing networks, and give insight into the specific processes that govern
the growth of networks.
The degree distribution of a network alone may be used to broadly classify networks. A commonly used network generative model is the random graph, or Erd sRényi network [36]. In this generative model some number of nodes is specified, and
all possible edges exists at some common probability independent of one another.
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Erd s-Rényi networks have a characteristic binomial degree distribution that converges on Poisson in the limit of many nodes, producing a degree distribution that
can be described in full by the mean of a Poisson distribution.
A common generative model with a notably different structure is the small-world
network model [37, 38, 39, 40]. In small-world networks, a ring lattice is constructed
to produce high local clustering. Edges in the network are then rewired, replacing
the end node of some edges with a random node. Depending on the proportion of
edges rewired, the final network is often similar, except with a notable reduction in
the average shortest path between nodes, hence the name small-world. Small-world
networks models are capable of reproducing structure found in social networks and
some neuronal networks of the brain [41, 42].
One of the more prominent categories of networks is those that take a heavytailed degree distribution, at times similar to a power-law distribution among others
[43, 44, 45]. Many real-world networks have a large number of nodes with low degree
and a small number of nodes with high degree, such as the internet and electrical
power grids [43]. This distribution may be found to remain scale-invariant, and
in such a case is known as a scale-free network. The Barabási-Albert model offers
an explanation for scale-free behavior with degree-based preferential attachment: a
network is grown one node at a time, adding edges to existing nodes in proportion
to their degree. The resultant network contains a scale-free degree distribution, in
which a power law closely fits the distribution.
If a network is known to have been formed by some generative process, the corresponding model may be able to closely reproduce the network with some parameterization. Since generative processes are typically stochastic, this parameter may follow
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a distribution of values capable of producing some observed network. This parameter
distribution may be inferred through Bayesian methods, given some observed network
and the target. Bayesian inference is a power statistical method, gleaning information
on the conditional probability of an event as evidence becomes available.

0.4

Approximate Bayesian computation

In cases where a likelihood function is intractable, approximate Bayesian computation (ABC) may be used to approximate the posterior distribution of a parameter
given some prior distribution [46, 47, 48, 49]. A versatile ABC algorithm is rejection
sampling, in which parameter values are first drawn from some prior distribution to
generate data. The generated data is then compared to the observed data with some
summary statistic, and if the difference between summary statistics is below some
level of error tolerance, the parameter value is added to the posterior distribution.
This posterior distribution is an approximation, converging on the true posterior distribution with reductions in error tolerance.
The parameterization of a generative model may be determined through the use
of rejection sampling ABC [50]. A network may be generated by a model under some
parameters, and if the network is similar enough in structure to the target network,
the parameters will be considered to belong to an approximation of the true posterior
distribution. As the tolerance for similarity shrinks towards zero, the computationally
determined posterior distribution converges on the true posterior parameter distribution. This requires some summary statistic to compare the generated graph graph to
the target. Numerous graph distances exist, such as graph edit distance, NetSimile,
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maximum common subgraph, and Laplacian spectral distance, among other spectral
distances [51, 52, 53, 54]. Each distance captures the structural differences between
graphs in different ways, with various algorithmic complexity: counting the number of
nodes and edges that must be added or removed, performing a function on summary
statistics such as degree and local clustering, or comparing the difference in eigenvalues of the adjacency or Laplacian matrices of two networks [54]. A distance measure
that is highly representative of the difference between between two graphs, or those
features desired for comparison, will produce greater confidence in the approximation of the posterior parameter distribution. Appropriate choice of this distance will
optimize the ability of ABC to estimate the true posterior distribution.
Identifying the growth mechanisms of genotype networks in particular could help
us understand the evolution of the pathogen itself. The preference for nodes by age
or degree may indicate which regions of a network contain strains that are actively
circulation or where new strains are likely to attach to a network. Such an understanding could influence predictive modeling of strains or even be used incorporated
into vaccination strategies.

0.5

Vaccine strain selection

High mutation rates in RNA viruses such as Zaire ebolavirus, Influenza A virus, and
Rabies lyssavirus lead to numerous contemporaneous strains [55, 56, 57? ]. Vaccines
are developed based on the antigenic properties of such viruses, however vaccine
effectiveness can be less than ideal: influenza vaccine efficacy is commonly below
50% [58, 59, 60, 61, 62]. Effective vaccination is challenged by both rapid evolution

13

of viruses away from the antigenic properties of strain(s) used for vaccines, and the
proper selection of strains for vaccines such that antibodies have a wide-reaching effect
on prevalent and future strains [63, 64, 65].
Each spring and fall, the World Heath Organization (WHO) makes recommendations for specific strains to be included in the influenza vaccine for each hemisphere.
WHO bases their recommendations largely on the current and forecasted incidence
of a particular strain in the upcoming flu season, as well as the availability of similar
vaccine viruses [66]. Although attention is given to the genetic and antigenic similarity between strains, further exploitation of available genomic data may be used to
inform their recommendations.
Chapter 4 will explore an approximation of vaccine efficacy through suppression
of outbreak potential in the presence of vaccinated strains. Cross-protective effects of
immunity, observed in viruses such as influenza, allow for genetically similar strains
to be influenced by nearby vaccines [67]. A genetic algorithm may be leveraged to
find ideal vaccination strains for a given genotype network, given the complexity associated with computation of interacting immune effects. Genetic algorithms evaluate
the effectiveness of a solution to a problem according to some measure of fitness. Solutions within a population are recombined, with selection preserving high-performing
solutions. This results in the convergence of randomly defined solutions on a high performing if not optimal solution [68]. In the application to follow, this will optimize the
location of vaccination strains to maximize immune coverage among observed strains.
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Chapter 1
On the Emergence of Multistrain
Epidemics with an Underlying Genotype Network
Abstract
Mathematical disease modeling has long operated under the assumption that any one
infectious disease is caused by one transmissible pathogen spreading among a population. This paradigm has been useful in simplifying the biological reality of epidemics
and has allowed the modeling community to focus on the complexity of other factors such as population structure and interventions. However, there is an increasing
amount of evidence that the strain diversity of pathogens, and their interplay with
the host immune system, can play a large role in shaping the dynamics of epidemics.
Here, we introduce a disease model with an underlying genotype network to account
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for two important mechanisms. One, the disease can mutate along network pathways
as it spreads in a host population. Two, the genotype network allows us to define a
genetic distance across strains and therefore to model the transcendence of immunity
often observed in real world pathogens. We study the emergence of epidemics in this
model, through its epidemic phase transitions, and highlight the role of the genotype
network in driving cyclicity of diseases, large scale fluctuations, sequential epidemic
transitions, as well as localization around specific strains of the associated pathogen.
More generally, our model illustrates the richness of behaviors that are possible even
in well-mixed host populations once we consider strain diversity and go beyond the
“one disease equals one pathogen” paradigm.

1.1

Introduction

Viral species are known to often undergo rapid evolution. Since the early 20th century,
influenza viruses have been described as having marked variability and unpredictable
behavior [1]. Subsequent RNA virus studies of the 20th and 21st century have focused
on, among others, the Zaire ebolavirus, strains of the SARS-CoV species, and HIV-1,
all possessing high mutation rates [2]. These frequent mutations contribute to the
antigenic evolution of these viruses, allowing them to evade recognition by the human
immune system [3].
Despite the long-standing knowledge of subtypes and strains within viral species,
mathematical disease modeling has continued to model viral diseases with one underlying pathogen. Notably, influenza violates the “one disease, one pathogen” paradigm:
numerous types, subtypes, and strains of influenza viruses challenge the human im-
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mune system, driving vaccine effectiveness below 50% in most recent years [4, 5, 6, 7].
Models which fail to account for antigenic variation of a pathogen may lead to biased
characterizations of epidemic emergence and progression.
Modeling multistrain pathogens with consideration for antigenic properties requires the inclusion of cross-protective effects, in which the immunity acquired towards
one strain offers partial protection towards another strain based on their antigenic
similarity. Cross-protection is seen in numerous viral species [8, 9, 10]. In general,
more similar strains will have greater cross-protective effects, as with seasonal influenza [11]. However, cross-protective immunity is not necessarily a monotonically
decreasing function of antigenic distance. Antibody-dependent enhancement has been
observed in dengue viruses, in which a past infection may in fact increase the risk
of severe infection [12, 13]. Regardless, approximations of cross-protection may be
made through antigenic distance or genetic distance. This relationship may be determined by a function of genetic distance to approximate the unique antigenic distances
between all strains.
Several models have been proposed in the growing sub-discipline of multistrain disease modeling [14]. These models balance biological assumptions with computational
tractability through reduction via symmetry (e.g. antigenic neighborhoods [15]) age
structure [16], and deciding to capture either infection history or immune status [14]
among other modeling choices. Cross-protective immunity has been explored in twostrain models [17], multistrain models with a restricted number of antigenic loci and
alleles [18], and temporary cross-protective immunity in dengue models [19] capable
of producing cyclical and chaos-like infection progression. However, the effects of an
underlying genotype network structure — governing viable mutation pathways and
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genetic distances between strains — have not been thoroughly explored with multistrain models. Genotype networks consist of nodes that represent strains, with edges
connecting strains that differ by one nucleotide or amino acid in some antigenic region of a gene or protein [20]. Genotype networks are a complementary structure to
phylogenetic trees, and are a useful way of representing genetic distance necessary for
cross-immunity in multistrain models.
Moreover, the genotype network gives us a proxy through which we can specify
potential mutation pathways between strains. Mechanisms for pathogen mutation
have previously been included in mathematical models[21, 22], often to consider the
emergence of antiviral resistance [23, 24, 25, 26]. Particularly, these models predict
the emergence of sequential epidemic transitions — with a first epidemic threshold
defining the emergence of macroscopic disease spread and a second marking the emergence of treatment resistant strain [24]. However, such models are often limited to
only two pathogen strains as they require specification of the fitness cost associated
with resistance. We therefore aim to introduce a more general model, allowing large
number of strains to mutate along specific network pathways. While this general
model could consider a complex fitness landscape over this genotype network, we focus on the case of neutral evolution and show how the previous results discussed here
can all co-exist within a single, fairly simple, model.
We introduce a multistrain Susceptible-Infectious-Recovered-Susceptible (multistrain SIRS) epidemic model with an underlying genotype network, allowing the
disease to evolve along plausible mutation pathways as it spreads in a well-mixed
population. We then investigate the effects of genotype network structure on the
emergence of an endemic state and on the fitness distribution of strains across the
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genotype network. Altogether, our results challenge the typical phenomenology of
epidemic models. We find two epidemic transitions: one marking the emergence of
an endemic state driven by a subset of strains well localized on the genotype network
and one marking a delocalization on the network, where all strains now contribute
to the endemic stain. Between these thresholds, we find chaos-like behavior which
can be maintained for arbitrarily long times, yielding time series with epidemic cycles
featuring large unpredictable fluctuations.

1.2

Model

We study the spread on infectious disease within a well-mixed population for a defined
genotype network of the chosen pathogen. Our model is as follows.
The underlying epidemiological dynamics correspond to a simple SIRS model, but
where we add a genotype network defined as a set of potential mutations, meaning an
infection of strain i œ [1, N ] can mutate along the network to a neighbouring strain
j œ Ni , where Ni specifies the set of first network neighbours of strain i. Biologically,
this network is defined such that neighbouring strains i and j differ by one unit of
genetic distance.
The strains spread within a well-mixed host population. Host individuals are
defined as susceptible (S) if they possess no immunity to any strain of a disease, see
Fig. 1.1. Susceptible individuals progress to infectious state Ii at transmission rate
— for every contact with individuals infectious with strain i, occurring at rate —Ii for
every susceptible individual. Note that this basic transmission rate is held constant
for all strains, as we focus on neutral evolution as a first approximation.
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Individuals in Ii can either: (i) recover at rate “ to state Ri and acquire direct
immunity for strain i and partial immunity to strain j ”= i; or (ii) become infected
with strain Ij via mutation at a rate µ for all strains j in Ni . Individuals in Ri will
either: (i) lose immunity and progress to S at rate –, or (ii) become infected with

strain j ”= i to which they only possessed partial immunity and progress to Ij at a

reduced rate — ú , where — ú is an exponentially decaying function of genetic distance
between strains i, j. Specifically:
— ú Ã 1 ≠ e≠xij /

(1.1)

where xij is the genetic distance between strain i, j (approximated by shortest path
of length xij = xji between strains i, j in the genotype network) and
immunity transcendence (0 <

is the rate of

< Œ).

Altogether, the dynamics of our model can be followed by the following set of
ordinary differential equations (ODEs),
N
N
ÿ
ÿ
dS
SIi
= ≠—
+–
Ri
dt
i=1 N
i=1

(1.2)

N
N 1
2IR
ÿ
ÿ
dIi
SIi
i j
=—
≠ “Ii + µ
Ai,j (Ij ≠ Ii ) + —
1 ≠ e≠xij /
dt
N
N
j=1
j=1

N 1
2I R
ÿ
dR
j i
= “Ii ≠ –Ri ≠ —
1 ≠ e≠xij /
dt
N
j=1

(1.3)
(1.4)

where Aij is an element of the adjacency matrix of the genotype network, equal to 1
if there is mutation pathway between i and j and 0 otherwise.
We therefore have 5 important epidemiological parameters: transmission rate —,
recovery rate “, rate of waning immunity –, mutation rate µ and immunity transcen26
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n
N
S
Ii
Ri

# strains
population size
susceptible
infected (strain i)
recovered (strain i)

—
“
–
µ

transmission rate
recovery rate
immunity loss rate
mutation rate
characteristic length of immunity transcendence

A
xij

adjacency matrix of the genotype network
shortest path length between strains i & j

Figure 1.1: Compartmental model of a multistrain epidemic with an underlying genotype
network (left), with parameters (right).

dence

. Unless mentioned otherwise, we typically fix the recovery rate “ = 1 such

that other rates are defined in units of infectious period (and

in units of genetic

distance). The other parameters then allow us to investigate different interesting
regimes,
As

æ 0, immunity becomes strain specific with no cross-protective effects. As

æ Œ, immunity becomes broad-reaching to the point of universal protection across

all strains. With — ú as a function of distance, we are able to reduce model complexity
by avoiding specification of —ijú among all strains, whose values may not be known in
real-world applications. Instead, we rely on the inverse relationship between antigenic

distance and cross-protection that has been observed in influenza viruses [11]. Note
that this relationship may not be monotonically decreasing for all pathogens, in which
case — ú may be defined by a function of genetic distance unique to the pathogens.
Our most important assumption is perhaps that only the most recent infection is
relevant for cross-immunity effects. Indeed, Ii and Ri specify the pathogen involved
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only in the most recent infection for every individual. The alternative would have been
to model an infectious state Ii,j,... for all unique infection histories, of complexity O(2n )
if order does not matter and complexity O(n!) if it does. While a big assumption,
focusing on the most recent infection reduces the complexity to O(n). Computational

feasibility would be largely restricted, which would limit the analysis of the effects
of genotype network structure [27, 14]. The infection history approximation enables
genotype networks to be large enough to contain complex structure, necessary to
investigate the role of genotype networks in epidemic progression.

1.3

Results

We focus our attention on the consequences of the genotype network underlying the
spread of the disease. In order to gain as much insights as possible on how it affect
prevalence of a disease, we keep the network itself simple using well-known graph toy
models composed of lattices, chains and stars.

1.3.1

Localization in genotype space

We first ask which strains can be expected to have an advantage, not because of their
own fitness or of our epidemiological parameters (as they all share the same —, “
and –), but because of their position in the genotype network. We use three simple
network structures — a star, a square lattice, and a chain, all containing 25 strains
— and run our model to produce a large outbreak with — = 25 much greater than the
expected SIRS epidemics threshold of —c = 1. Accordingly, we set the evolutionary
dynamics to be much slower than that of epidemic spread with µ = 10≠3 . We then
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Figure 1.2: Infection localization and characteristics of endemic infection state. (Top)
Localization within networks shown by endemic infection counts Iiú normalized by max(Iiú )
for a given network. We use mutation rate µ = 10≠3 , transmission rate — = 25, waning immunity rate – = 1/50, and transcending immunity = 4. (Middle) Infection localization
regimes are revealed where normalized effective sample size is low (lattice and chain), occurring when few strains account for the majority of infections. (Bottom) endemic infections
depend on not only transmission rate —, but also the breadth of cross-protective effects
determined by transcendence rate . Fixed parameters are n = 25, µ = 10≠3 , – = 1/50.

let the system reach its endemic steady state, where the derivatives in Eqs. (1.2-1.4)
essentially go to zero such that the system is at equilibrium.
We observe a localization of infections by strain within genotype networks as
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shown in Fig. 1.2, top row. Stationary or endemic infection counts Iiú differ from
strain to strain, even with the assumption of neutral evolution, based solely on their
position in the network and the resulting cross-protective immune effects. Epidemics
can therefore be localized around a minority of strains, as is clear in the lattice and
chain networks.
We quantify this localization phenomena with Kish’s effective sample size [28],
q

referred to here as effective participation ratio núef f = nef f /n = (

Ii )2 / (n

q 2
I ).
i

As

núef f æ 1, all strains contribute an equal number of infections. As núef f æ n≠1 , only
one strain contributes infections. In Fig. 1.2, top row, we observe lower núef f in the

lattice and chain, indicating greater localization. A small number of strains are able
to escape strong cross-protective immunity in the corners of the lattice and at the
ends of the chain, while such heterogeneity is not seen in the star and ring networks.
As network structure determines infection localization, so does the transcendence
of immunity. In Fig. 1.2, middle row, we see núef f as a function of — and immunity
transcendence

, revealing regimes of strong localization in the lattice and chain

networks where núef f remains small. High values of

> 10, indicating far-reaching

cross-protection, are associated with localization in these two networks. The structure
of the star and loop networks allow them to escape localization effects influenced by
large

.

Stationary infection counts I ú are also influenced by immunity transcendence
In Fig. 1.2, bottom row, we see reductions in I ú as

.

increases. As cross-protective

effects increase, a higher — becomes necessary to maintain infections. Again we see
the importance of network structure, with different values of
networks to affect I ú .
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required between

1.3.2

Sequential phase transitions

We then look at the behaviour of the endemic state as we vary the basic transmission
rate —. We know from classic SIRS model that there should be an epidemic transition
at —c = 1, marking a transition between a disease-free phase where the disease is too
weak to establish itself in the population if — < 1, and an endemic phase for larger
values. Yet, one interesting result of Fig. 1.2, bottom row is that the epidemic
threshold now seem to increase with transcending immunity
surprising given that

. This is somewhat

does not matter for any one strain, which should still be able

to survive on its own following SIRS dynamics once — > —c = 1.
In Fig. 1.3, we take a deeper look at the phase diagram under varying transmission
rate and observe a second epidemic transition. More precisely, if – is not too large,
I ú is no longer a concave function of the transmission rate; it emerges as expected
at —c = 1 but has a new inflection point at a much higher — value. This means that
only modest increases in I ú are seen when — is just above to the epidemic threshold
—c = 1, in contrast to standard SIS-like models in which this regime experiences the
most rapid rate of change in I ú as a function of — [29].
We conjecture that this second phase transition is governed by what we call the
immune invasion threshold, corresponding to the point at which infected nodes starts
to infect recovered nodes (of other strains) effectively. To see this, in Fig. 1.3(a), we
compare the bifurcation diagrams of two models: with and without waning immunity.
In the latter case, in the stationary state, a node infected with strain i can only infect
recovered nodes of strains j ”= i (since S ú = 0). The immune invasion threshold —I

can thus be estimated from —c if – ‘æ 0. Surprisingly, even though —c = 1 whenever
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Figure 1.3: Bifurcation diagram for the model with varying levels of waning immunity on
a star genotype network with 10 strains. We fix the recovery rate to “ = 1, the mutation
rate µ = 1/100, the transcending immunity
= 10 and we vary the transmission rate —.
(a) We set the waning immunity rate – œ {0, 0.02} to illustrate the origin of the immune
invasion threshold (vertical dotted line) obtained with Eqs. (1.5) and (1.6). (b) For large
enough values of waning immunity rate, the immune invasion threshold disappears because
recovered nodes quickly become susceptible again.

– > 0, it is no longer the case when – = 0.
To derive the immune invasion threshold, let us rewrite the stationary state quantities I ú , Rú when – = 0. We have
0 = ≠“Iiú + µ

ÿ
j

0 = “Iiú ≠ —Riú

Aij Ijú ≠ µki + —Iiú

ÿ

ÿ

Tij Rjú ,

j

Tij Ijú ,

j

where Tij © (1 ≠ e≠xij / ). Isolating Riú in the second equation and reinjecting the
solution in the first one, we obtain a self-consistent equation for the {Iiú },
Iiú

=

“
µ

3

q

j

1≠

q

Aij Ijú

q
j Tij

k

Ijú
Tjk Ikú

4

+ ki

.

(1.5)

Interestingly, the {Iiú } do not depend upon —. However, we know that such
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solution is possible only if Iiú > 0 ’i, and this break down at —I when Rú =

q

i

Riú æ 1.

Therefore, the immune invasion threshold —I has the following explicit expression
—I = “

ÿ
i

Iiú
,
q
ú
j Tij Ij

where the {Iiú } are evaluated from Eq. (1.5).

We observe a direct relationship between

and —I . Namely, when

Tij æ 0 for all i, j, hence —I æ Œ, as seen from Eq. (1.6). When
all i ”= j, and Tii = 0, hence

—I æ “

ÿ
i

q

increasing

Iiú

j”=i Ij ú

For large networks, —I ¥ “ © 1 in the limit

(1.6)

æ Œ,

æ 0, Tij æ 1 for

.

æ 0. Therefore, we conclude that

increases the immune invasion threshold, which makes sense based on

intuition alone.
This relationship is shown in Fig. 1.4 for the three toy networks across multiple
values of

. As

increases, immunity becomes wide-reaching in genetic distance, ap-

proaching the effects of universal immunity or a universal vaccine. This has the effect
of necessitating higher — to produce the same I ú as lower values of

. Importantly,

because of the sum in the denominator of Eq. (1.6), the immune invasion threshold —I
is not simply set by the diameter of the genotype network (i.e., the maximum value
of xij ), and is instead set by the entire network structure. While strains maximally
distant from each other can of course better infect recovered individuals, competition
between strains also play an important role: central strains can still infect individuals and grant them better immunity due to their central position in the network.
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Figure 1.4: Integration of the ODEs on three toy genotype networks — the chain, square
lattice and star — all with 25 strains. We fix the recovery rate “ = 1, the mutation rate
µ = 1/100, the waning immunity rate – = 1/50 and vary the transmission rate — under
three values of transcending immunity: (a)
= 5, (b)
= 10, (c)
= 50. Close to the
inflection point of every I ú curve (shown in solid lines) we find a maximum in Rú (shown
in dashed lines). This point therefore marks a second activation threshold, one where
the transmission rate is high enough to counteract transcending immunity and spread the
outbreak using the pool of recovered individuals.

Thus, the network structure plays a nontrivial role in setting the exact value of —I as
determined by Eq. (1.6).

1.3.3

Rich dynamics between epidemic thresholds

Beyond the features of the endemic state, we observe rich prevalence dynamics throughout the epidemic when transmission rates are between the epidemic threshold —c = 1
and the immune invasion threshold —I Ø —c . By comparing the top, middle, and
bottom rows of Fig. 1.5 we see infection counts throughout the epidemic simulation
while the transmission rate lays in different regimes, decreasing from — > —I to values
closer to —c = 1.
For transmission rate below the immune invasion threshold (bottom two rows),
we see oscillations in the overall infection counts across all three networks before
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Figure 1.5: Integration of the ODEs on three toy genotype networks — the chain (left
column), square lattice (middle column) and star (right column) — all with 25 strains.
We fix the recovery rate “ = 1, the mutation rate µ = 1/1000, the waning immunity
rate – = 1/5000 and the transcending immunity
= 4 and vary the transmission rate:
— = 25 (top), — = 1.7 (middle), — = 1.1 (bottom). The system is initialized with a small
fraction 10≠5 of infections on an “end strain” (end for the chain, corner for the lattice,
leaf for the star). On the chain we see successive activation of all strains, with the system
stabilizing once the entire network is explored and evolution reaches a dead-end. The star
sees cycles caused by activation of the leaf strains. The lattice is much more interesting,
with loops causing a random-like succession of strains to cycle. The dynamics become more
interesting for the bottom row, with transmission rates between the epidemic and immune
invasion thresholds, with cycles and chaos-like dynamics. The closer we get to the true
epidemic thresholds —c = 1, the longer the interesting transient dynamics.
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converging on an endemic value, resembling a dampened pseudo-chaotic behavior.
Noting the different time scales shown, the chain rapidly converges on its endemic
state while the star undergoes drastic oscillations before convergence. We see variation
in infection counts at the strain level, with the infection counts for 3 of the 25 strains
shown. At the strain level we see convergence occurring on different time scales within
the same network, as well as variability in oscillatory nature.
In comparison, the top row of Fig. 1.5 shows the rapid convergence on the endemic state when the transmission rate is high (— = 25). There still exists infection
localization, as indicated by different endemic infection counts at the strain level,
as well as variability in convergence time between strains. However, the oscillatory
nature is profoundly absent at transmission rates well about —I . In contrast, as transmission rates are lowered towards —c = 1 in the bottom rows of Fig. 1.5, we see
the oscillations preserved but stretched across a broader timescale. Importantly, as
the timescale of oscillations is stretched, their minimal values decrease by orders of
magnitude. In practice, this shows that any finite size simulations of the dynamics captured by our model would likely lead to strain extinction, with potential to
reemerge through mutations. Discrete events are unfortunately not captured in ODE
models as they assume continuous values, or infinite population.

1.4

Conclusion

The introduction of an underlying genotype network to a multistrain model has
demonstrated the emergence of cyclicity, infection localization, and sequential phase
transitions, all in one model. Simple mathematical arguments have allowed us to
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solve for the transitions observed and highlight the nontrivial impact of the structure
of the genotype network. Rich infection dynamics are seen between the epidemic
threshold and the immune invasion threshold. Altogether, what these results show is
that many features of infectious disease dynamics often explained by environmental
factors or host behaviour, such as cyclicity [30], unpredictability [31] and sequential
transitions [32], can also be explained by adding a layer of biological complexity in
the form of a genotype network. Our results thus highlight the importance of going
beyond the “one disease, one pathogen” paradigm, with complex dynamics emerging
from even the most simple genotype network structures.
Future work needs to be done to integrate this modelling approach with real
genomic data. Likewise, the interplay of our results with the finite size and the contact
structure of the host population needs to be investigated; as does the role of strain
extinction and emergence. Different modelling approaches will need to be considered,
such as explicitly modeling the growth and evolution of the genotype network as it
co-evolves (albeit on a different timescale) with the spread of the infectious disease in
the host population. Coupling the large modeling literature on growing networks [33]
with that of network epidemiology [29] should lead to a richer understanding of how
networks, both biological and social, impact epidemics. Finally, this type of models
could also be appropriate to re-imagine vaccination strategies. The literature on
targeted immunization and influential spreaders on networks could then be leveraged
[34, 35, 36, 37], but rather than targeting central individuals the objective would be
to best hinder and block the immune evasion of the pathogen as it mutates along its
genotype network.
In terms of applying these models to specific scenarios, there is a need for unbiased
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pathogen genomic data, as well as an understanding of their antigenic properties, to
inform models that account for these features using real-world data and to refine
the cross-protective immune effects between strains of a pathogen. Similarly, we
need more realistic models to take advantage of the growing body of genomic data
available and refine the mechanisms driving mutation and immunity. We call for the
refinement of immune mechanisms and immune history to allow their incorporation
in mathematical disease models. Further understanding of how pathogens explore
genotype space, the growth of genotype networks, the role of host immunity towards
past strains, and the influence of the above on the fitness landscape of pathogens
will better inform models incorporating multiple strains, cross-protective effects, and
evolution of a pathogen.
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Chapter 2
On the Genotype Network of Influenza A (H3N2) Hemagglutinin
Abstract
Seasonal influenza is a virus of global public health concern, with multiple everchanging strains in circulation. A high mutation rate enables the influenza virus
to evade recognition by the human immune system, including immunity acquired
through past infection and vaccination. Here, we capture the genetic similarity
of influenza strains and their evolutionary pathways with genotype networks. We
show that influenza A (H3N2) hemagglutinin genotype networks are characterized by
heavy-tailed component size and degree distributions suggesting critical-like behavior,
as well as a growth process suggesting temporally-restricted preferential attachment.
We argue that: (i) genotype networks are driven by mutation and host immunity to
explore a subspace of networks predictable in structure, and (ii) genotype networks
provide an underlying structure necessary to capture the rich dynamics of multi42

strain epidemic models. In particular, inclusion of strain-transcending immunity in
epidemic models is dependent upon the structure of an underlying genotype network,
revealing edge densities that maximize endemic infections. We conclude that genotype networks provide a model that enables network analysis of pathogen evolution
and realistic multistrain epidemic models.

2.1

Introduction

Each year, seasonal influenza results in 290,000 to 650,000 deaths globally, 9 million
to 36 million cases in the United States alone, and a significant economic burden
[1, 2, 3]. Despite widespread vaccination and increased surveillance efforts in recent
years, influenza continues to show prominent seasonality in temperate regions and
causes a year-round burden in tropical regions [4]. Risk for severe outcomes is nontrivial in at-risk populations, including young children, the elderly, pregnant women,
and persons with certain pre-existing conditions [5]. The risk for severe outcomes in
these groups is further elevated in low- and middle-income countries, a concerning
relationship given the global prevalence of influenza [6].
Influenza viruses mutate at a high rate, leading to frequent strain emergence [7].
These novel strains may be antigenically different enough to escape recognition in the
host by previously acquired antibodies. As a result, circulating strains of influenza are
constantly changing, challenging the human immune response and necessitating yearly
updates to vaccine strains. Optimal vaccine strain selection is dependent upon the
ability to both forecast prevalent future strains and select a limited number of vaccine
strains, such that these strains offer optimal immune protection by leveraging strain-
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transcending immunity [8, 9]. Modern seasonal influenza vaccines induce antibodies
for three to four unique strains of influenza, providing direct immunity for these strains
and cross-protective (or strain-stranscending) effects towards antigenically similar
strains. Likewise, these antibodies are induced in response to an influenza infection.
Antibodies will not offer protection against all strains, but only those identical to or
antigenically similar to the strain that induced the antibodies [10]. This finite straintranscendence of immunity, in which antibodies for one strain offer protection against
only antigenically similar strains, is what allows influenza to persist year after year.
Genotype networks have previously been constructed from the highly antigenic
hemagglutinin (HA) protein sequences of influenza [11]. The networks revealed features not well represented in phylogenetic trees, such as convergent evolution, the
identical trait evolution in separate lineages. These networks were prone to fragmentation in the presence of low sampling rates, reducing the number of observed plausible
evolutionary pathways. Sample rates have increased dramatically since Wagner 2014,
calling for a more accurate account of the evolution of influenza genotype networks
[11].
In this investigation we utilize a genotype network to capture the genetic relationship between strains of influenza A (H3N2), a prominent subtype from 2010 to
2020. Sequences of the highly antigenic HA protein of influenza A (H3N2) will be
used to explore the structure and temporal evolution of the genotype network and
its exploration of genotype space. Finally, a multistrain epidemic model is implemented to explore the role of edge density in determining infections in the context of
strain-transcending immunity.
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2.2
2.2.1

Methods
Network generation

Protein sequences were obtained for complete influenza A (H3N2) HA samples from
the Influenza Research Database [12]. Samples acquired from the Influenza Research
Database are sourced from the databases that include NCBI GenBank and RefSeq.
Samples were restricted to a collection date of January 4, 1999 to October 1, 2019
and collection from human hosts only, obtained on January 16, 2020. A 3 month
delay between final sample collection date and data retrieval date was implemented
to account for delays in data reporting.
A total of 30,175 sequenced samples for HA were obtained. Sequences were further
restricted to allow for the precise genetic sequence comparison required for network
edge construction. Samples with missing or uncertain residues (n = 1, 278) and
sequences with more or less than 566 amino acids (n = 17) were removed. The
remaining 28,880 samples were condensed into set V of 6,494 unique sequences.
The number of differing amino acids across all sites, dv,w , was found for all pairs
of sequences of length l, where l = 566:

dv,w =

l
ÿ
i=1

x, where x =

Y
_
_
_
]1,
_
_
_
[0,

if vi ”= wi
if vi = wi

v, w œ V

An edge ev,w is formed where dv,w = 1. Each edge indicates a plausible, but not definitive, mutation pathway between two viable strains that requires one point mutation,
thus no intermediate strains nor multi-mutation events. The resulting genotype net45

work is defined as G = (V, E), where E is the set of all edges ev,w .
Temporal analyses restricted data by year using seasonal trends of the Northern
Hemisphere, given its dominance of the data set. Sequences were binned according
to a 5 year window, where each year consisted of July 1 through June 30 of the
following year. A 5 year window centered on 2010 would contain sequences from July
2007 through June 2012.
Distribution tails were fit with power laws using the ‘poweRlaw’ package [13].
Minimum x values fit were constrained to xmin = 2 for networks consisting of 5 years
of data, while the network across all years was fit using a minimum x value of at least
5, found to be xmin = 7 for both degree and component size by poweRlaw.

2.2.2

Multistrain epidemic model

The multistrain epidemic model implements the compartment model of Chapter 1
(see Chapter 1, Figure 1.1). Susceptible individuals S may become infected by any
strain i at rate —, progressing to infected state Ii . Individuals in Ii either recover to
the corresponding recovered state Ri or become infected with a neighboring strain
j in the genotype network at mutation rate µ. Recovered individuals in state Ri
return to S at immunity loss rate –, or become infected by strain j where j ”= i .
Transmission from strain j to an individual in Ri is weighted by a decaying function
of the distance between strains in the genotype network:

— ú = —(1 ≠ e≠xij
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≠1

)

(2.1)

for shortest path xij between strains i, j, and transcendence of immunity parameter
.
Immunity remains strain-specific where

= 0. Small values of

correspond

to acquired immunity that protects best against only the most similar strains, with
minimal protection against distant strains. Large values of

provide partial immune

protection of greater range and strength. Note that the shortest path between nodes
is an approximation for number of differing amino acids, which may differ slightly.
This compartmental model was implemented with a system of differential equations containing one susceptible state and an infected and recovered state for each
strain. The model assumes that: (i) an individual may be infected by at most one
strain at a time, (ii) an individual may possess acquired immunity for at most one
strain at a time, and (iii) transcendence of immunity decays exponentially as a function of the distance between strains (Equation 2.1).

2.3
2.3.1

Results
Influenza A (H3N2) HA genotype network

The influenza A (H3N2) HA genotype network represents 28,880 samples of HA from
1999 to 2019, resulting in 9,714 nodes (unique strains), 7,599 edges (possible point
mutations between strains), and 3,262 connected components, of which 384 consist of
more than one node. With 29.6% of nodes of degree k = 0 and 44.0% of k = 1, the network features a heavy-tailed degree distribution, stretching up to a maximum degree
of 256. The tail of the complementary cumulative distribution function (CCDF) of
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Figure 2.1: Influenza A (H3N2) HA genotype network degree and component size distribution. (left) CCDF of degree. The tail of degree distribution does not significantly differ
from a power-law distribution with –k = 2.29 for kmin = 7 (p = 0.11, –significance = 0.05, 103
repetition Kolmogorov-Smirnov test). (center) CCDF of component size. Component size
distribution does not significantly differ from a power-law distribution with –c = 1.66 for
cmin = 7 (p = 0.59, –significance = 0.05, 103 repetition Kolmogorov-Smirnov test). (right)
Sample count of a sequence vs. degree k of corresponding node. Sample count is highly
correlated with node degree (ﬂ = 0.941).

degree, P (K Ø k), exhibits power-law behavior: P (K Ø k) Ã k ≠–k where –k = 2.29
for minimum degree kmin = 7 (Figure 2.1, left). This is in agreement with the the
heavy-tailed degree distribution found by Wagner in the largest connected component, or the giant component, of a smaller data set from 2002-2007 [11]. This degree
distribution suggests that in a generative model of such a network, approximately
linear preferential attachment would be necessary to reproduce a comparable degree
distribution [14].
The distribution of component sizes of the genotype network is similarly heavytailed. The tail of the CCDF of component sizes P (C Ø c) follows a power-law
distribution, where P (C Ø c) Ã c≠–c with –c = 1.66 for minimum component size

cmin = 7 (Figure 2.1, center). This scaling may be suggestive of a self-organized
critical process in the formation of the genotype network.
The degree of a node and the number of times its corresponding sequence was
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sampled are highly correlated (Figure 2.1, right). This suggests that high degree
nodes are robust to reduced sampling, given that the duplicate sample count of a
strain may be a proxy for its population prevalence. This is akin to the robustness
of scale-free networks towards random failures, with sample count taking place of
degree [15]. Consequently, increased surveillance has likely identified more strains of
low prevalence given that low-degree strains are more likely to be removed from the
network with random sub-sampling.
The network contains numerous cycles amidst its tree-like structure. Its 500 triangles indicate mutations at the same site between 3 sequences, while sparse squares
indicate potential convergent evolution [11]. These structures are clearly displayed
in genotype networks, while phylogenetic tree construction do not include convergent
evolution structurally. The treelike topology of the network prevents longer cycles
from forming. Further network summary statistics are shown in Table 2.1 for the
enture network G and the giant component GC. The triangles are captured by global
clustering Cglobal , which is equivalent to the proportion of triplets (3 connected nodes)
that form a closed triangle.
n

m

kmean

kmax

diameter

Cglobal

ﬂk

G

9714 7599

1.86

257

-

0.0096 -0.13

GC

1629 2225

2.73

257

17

0.0010 -0.20

Table 2.1: Network statistics for entire network G and giant component GC.

The degree assortativity ﬂk represents the correlation between the degree of a
node and its neighbors (Table 2.1). A negative value for both the entire network
G and the giant component GC indicate that high degree nodes tend to attach to
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low degree nodes, as is true conversely. Future investigation of vaccination strategies
may consider potential high-degree hubs as immunization targets, given their high
neighbor count and the transcendence of immunity in influenza A (H3N2) viruses, as
well as potential bridges between highly connected regions of the network.

2.3.2

Network topology in time

The genotype network grows in time as new strains emerge and are sampled. The
growth of the second largest component is shown in Figure 2.2, with each node colored
by the first sample date of its corresponding strain. This component is large enough
to span several years while remaining small enough to qualitatively observe network
growth in time. The blue-shifted nodes represent the earliest observed strains among
those belonging to this component, the first of which was sampled in late 2010.
The majority of unique strains were sampled from 2012 to 2015, including multiple
high-degree strains and their neighbors. The most recent strains from this network
component are red-shifted, clearly depicting the tree-like growth process.
Numerous hubs are seen throughout the network, with the largest hubs existing
around the 2012-2013 flu season that contributed numerous strains to this component
(Figure 2.2, bottom). Seasonality is reflected in the sample date distribution of this
component, with multiple peaks around the start of the calendar year during flu
season.
Features of the genotype network remain fairly stable in time, even in the presence
of a constantly increasing sampling rate. Genotype networks were constructed using
samples within a 5 year window, sweeping across the entire sample set from 1999
to 2019. These temporally restricted genotype networks display the structure of the
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Figure 2.2: Sample dates among strains of second largest network component. (top)
Nodes colored by first sample date (8 nodes with lacking sample dates colored black), with
a larger radius corresponding to more samples (max sample count 337). (bottom) Sample
date distribution across all dated samples of strains within the above network.

network local in time, an important consideration given that strains emerge and fall
out of circulation. These networks display the increased availability of sequenced
samples with each successive year, with notable increases in sampling since 2008
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Figure 2.3: Network statistics in time. Influenza A (H3N2) HA genotype networks generated using samples within a sweeping 5 year window from July 1999 through June 2019,
shown at midpoint. (left) Number of nodes and edges for entire network and giant component. (center) Power-law fit exponents –c and –k, GC with cmin = kmin = 2. (right)
Global clustering coefficient Cglobal in time.

(Figure 2.3, left). The number of nodes and edges has grown steadily in the past 2
decades across both the entire network of the 5 year windows and its giant component.
Scaling of both degree distribution and component size distribution tails remain
fairly constant in time. The power-law exponent for degree varied within 2.27 <
–k < 2.63, showing a modest increase in time, even as the network grew several times
larger (Figure 2.3, center). Similarly, the power-law exponent for component size
varied within 1.90 < –c < 2.13, showing a weaker relationship with time and sample
rate than –k as the network grew (Figure 2.3, center). This shows that component size
distribution approximately maintains the same scaling factor in time, while degree
shows a slight increase in its scaling factor as more samples are contained within a
5 year window. This may result from the probable increase in the detection of lowdegree nodes when sampling rates are high, shifting –c to a steeper or higher value.
Note that minimum values cmin and kmin were fixed at 2 to remove the effects of
varying minimum values on the power-law fit on smaller networks, and may not be
directly comparable to values shown in Figure 2.1 where cmin = kmin = 7.
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Local cycles continue to remain prevalent in the network through time. The global
clustering coefficient varied within 6.78◊10≠3 < Cglobal < 1.27◊10≠2 , showing greater
variability than scaling factors (Figure 2.2, right). Similarly, degree assortativity
varied within ≠0.365 < ﬂk < ≠0.124, demonstrating variability but preserving the

disassortative structure of the network. The above features demonstrate that in
the presence of variable sequence sampling rates, genotype networks possess fairly
consistent topological features that are highly predictable from recent years.

2.3.3

Epidemics in random graphs

To investigate how genotype network structure may influence the spread of disease,
a multistrain SIRS model was constructed with an underlying network of strains
(2.2.2: Methods). The incorporation of a genetic strain structure allows for both
mutation between neighboring strains and cross-protective immune effects, existing
as a function of genetic distance.
The connectivity or edge density of a genotype network may influence its endemic infection capacity, as suggested by cross-protective immune effects and the
observed criticality within the genotype network structure. Here the effects of connectivity were investigated with the implementation of the multistrain model on G(n, p)
Erd s–Rényi (ER) random networks, for number of nodes n and edge probability p
controlling connectivity. Endemic infection proportion I ú was observed across varying edge densities and levels of immunity transcendence to determine their effects on
endemic infections for a genotype network of a given size.
Non-trivial dynamics are revealed by the multistrain epidemic model with an
underlying genotype network structure of ER random networks. Endemic infec53
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Figure 2.4: Endemic infections I ú as a function of ER random network edge density p and
transcending immunity parameter , using SIRS model with underlying genotype network.
Median across 200 repetitions shown with 10th and 90th percentiles, shaded. Network size
n = 25, mutation rate µ = 1/50, transmission rate — = 1/2, recovery rate “ = 1/6, immune
loss rate – = 1/100.

tion proportions I ú are lowered in ER random genotype networks in the presence
of high connectivity and non-zero transcending-immunity parameter

, producing

cross-protective immune effects (Figure 2.4). Low connectivity resulted in lower I ú
through increased fragmentation, resulting in numerous components that restrict mutation pathways between all strains. Together these dynamics produce an optimal
connectivity that may be influenced by the parameterization of the multistrain model.
An optimal edge density is observed at approximately p = n2 , close to that of the critical transition probability pc =

1
n≠1

above which a giant component is expected.

Around this critical transition, the random networks are known to have a power-law
distribution of component sizes with exponent 1.5, close to the behaviour observed in
Figure 2.3, center [16].
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It is noted that the ER random networks are distinct in topology from the scalefree genotype networks observed for influenza A (H3N2) HA, and further exploration
is required to understand the effects of edge density given different general network
topologies.

2.4

Discussion

The influenza genotype networks explore a subspace of all networks that is predictable
in structure as they grow in time. Features such as scale-free degree distributions and
component size distributions remained present and fairly consistent in networks generated using temporal subsets of strain samples. This suggests that although future
strains arise through stochastic mutation events, their effect on network structure may
be predictable. Given the numerous mutations possible, it may not be possible to
predict new strains with meaningful accuracy. However, it may be possible to predict
their genetic relationship to strains existing in the network structure. Assuming the
genetic distance is proportional to antigenic distance, this is a consequential development related to the understanding of cross-protective immune effects and vaccination
strain selection.
The topology of influenza A (H3N2) HA genotype networks indicate that it may
be influenced by strain-transcending immunity. This is further suggested by the
dynamics of a multistrain epidemic model. The power-law degree fit is also steeper
when lower degree nodes are consider (k < 7), indicating that high degree nodes
are more prevalent than would be expected were there one scaling regime across all
observed degrees. This corresponds to the presence of more hubs than would be
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expected through degree-based preferential attachment. An possible explanation for
this observation is that strain extinction prevents new nodes forming via mutation
from older hubs, enabling the growth of new hubs.
The strong positive relationship between degree and sample count implies preferential attachment based on degree, however node age implements a consequential
maximum age at which a node may be acquire new neighbors. This corresponds to
the point at which the strain is not widely circulating or extinct in the host population. Furthermore, the multistrain model suggests that strain-transcending immunity
drives this strain extinction process as cross-protective effects increase population immunity towards strains in time.
Together these observations suggest that influenza genotype networks explore a
subspace predictable in structure, influenced by the effects of strain-transcending
immunity. We call for the increased genomic surveillance of multistrain pathogens
allow for similar analyses of other diseases with variable antigenic properties. Further
analysis of influenza genotype networks may be considered for vaccine strain selection,
analysis of evolutionary trajectory, and refinement of the understanding of crossprotective immunity.
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Chapter 3
On the Approximate Bayesian Computation of Age-Weighted Preferential Attachment Models
Abstract
Real world networks may arise from undefined or partially understood generative
processes. Proposed generative processes may be evaluated through the approximate
Bayesian computation (ABC) of generative model parameters, identifying parameter
values that lead to a desired network structure, if any exist. Here we investigate the
use of ABC to identify parameter distributions that allow network generative models
to reproduce some target network constructed by an unknown generative process. We
ground this investigation in a real-world application by defining the target network
to be a genotype network of the influenza A (H3N2) hemagglutinin (HA) surface
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protein of antigenic and evolutionary significance. We show that (i) sufficient posterior
distribution convergence is achieved across multiple generative models, (ii) nonlinear
relationships exist between preference for degree and age when fitting a generative
model to some target network, and (iii) age-weighted preferential attachment can
improve the ability of a generative model to reproduce a viral genotype network.
This shows that ABC is able to reverse-engineer the generative processes of a network
through model evaluation, and that simple age-weighting functions may be used in
combination with degree preference to create diverse network structures.

3.1
3.1.1

Introduction
Networks generative models

Network generative models are tools used to construct networks, explain features of
existing networks, and give insight into the specific processes that govern the growth
of networks. Networks are complex structures, with information contained in their
topology that may be extracted via understanding the process by which the network
formed. The degree distribution of a network alone may be used to broadly classify
networks. A commonly used network generative model is the random graph, or Erd sRényi network [1]. In this generative model some number of nodes is specified, and all
possible edges exists at some common probability, independent of one another. Erd sRényi networks have a characteristic binomial degree distribution that converges on
Poisson in the limit of many nodes, producing a degree distribution that can be
described in full by the mean of a Poisson distribution. A common generative model
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with a notably different structure is the small-world network model [2, 3, 4, 5]. In
small-world networks, a ring lattice is constructed to produce high local clustering,
such that the neighbors of a node are likely to be connected to one another. Edges in
the network are then rewired, replacing the end node of some edges with a random
node. Depending on the proportion of edges rewired, the final network is often similar,
except with a notable reduction in the average shortest path between nodes, hence the
name small-world. Small-world networks models are capable of reproducing structure
found in social networks and some neuronal networks of the brain [6, 7].
One of the more prominent categories of networks is those that take a heavytailed degree distribution, at times similar to a power law distribution among others
[8, 9, 10]. Many real-world networks have a large number of nodes with low degree and
a small number of nodes with high degree, such as the internet and electrical power
grids [8]. This distribution may be found to remain scale-invariant, and in such a case
is known as a scale-free network. The Barabási-Albert model offers an explanation
for scale-free behavior with degree-based preferential attachment: a network is grown
one node at a time, adding edges to existing nodes in proportion to their degree.
The resultant network contains a scale-free degree distribution, in which a power law
closely fits the distribution.
If a network is known to have been formed by some generative process, the corresponding model may be able to closely reproduce the network with some parameterization. Since generative processes are typically stochastic, this parameter may follow
a distribution of values capable of producing some observed network. This parameter
distribution may be inferred through Bayesian methods, given some observed network
and the target. Bayesian inference is a power statistical method, gleaning information
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on the conditional probability of an event as evidence becomes available.

3.1.2

Approximate Bayesian computation

In cases where a likelihood function is intractable, approximate Bayesian computation
(ABC) may be used to approximate the distribution of a parameter [11, 12, 13, 14].
A versatile ABC algorithm is rejection sampling, in which parameter values are first
drawn from some prior distribution to generate data. The generated data is then
compared to the observed data with some summary statistic, and if the difference
between summary statistics is below some level of error tolerance, the parameter value
is added to the posterior distribution. This posterior distribution is an approximation,
converging on the true posterior distribution with reductions in error tolerance.
The parameterization of a generative model may be determined through the use
of rejection sampling ABC [15]. A network may be generated by a model under some
parameters, and if the network is similar enough in structure to the target network,
the parameters will be considered to belong to an approximation of the true posterior distribution. As the tolerance for similarity shrinks towards zero, the computed
posterior converges on the true posterior for the parameters. This requires some summary statistic to compare the generated graph graph to the target. Numerous graph
distances exist, such as graph edit distance, NetSimile, maximum common subgraph,
and Laplacian spectral distance, among other spectral distances [16, 17, 18, 19]. Each
distance captures the structural differences between graphs in different ways, with various algorithmic complexity: counting the number of nodes and edges that must be
added or removed, performing a function on summary statistics such as degree and
local clustering, or comparing the difference in eigenvalues of the adjacency or Lapla62

cian matrices of two networks [19]. A distance measure that is highly representative
of the difference between between two graphs will produce greater confidence in the
approximation of the posterior parameter distribution.

3.1.3

Genotype networks and age-weighted preferential attachment

Bayesian inference of network generative model parameters can be used to understand
the mechanisms that produce a network, which is of particular importance when the
mechanisms are largely unknown. ABC may be used to evaluate parameterizations
leading to a particular network under a proposed generative model. The parameters
and their approximated posterior values can inform the preference for attachment
based on degree, as with nonlinear preferential attachment, or other parameters,
such as preference based on the age of a node.
Here we conduct a practical application of ABC on network generative methods,
for a genotype network of the hemagglutinin (HA) protein of influenza A (H3N2). In
this network each node represents a unique sequence of HA, defined here as a strain,
with edges connecting sequences that differ by one amino acid, indicating a plausible
mutation pathway. The parameterizations of generative models that most closely fit
this network offer insight on how it grows in time, and consequently, the evolution of
this protein of the influenza A (H3N2) virus.
An important factor in the formation of genotype networks is time, as new strains
are likely to be found in the genetic neighborhood of prevalent strains at a given time
[20]. It may be possible to capture this behavior by using age-weighted preferential
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attachment, by which the age of a node is a factor for how likely a new node is
to attach to it [21]. A variety of age-weighted preferential attachment functions
were explored to: (i) identify parameterizations of each model that best reproduce
the target genotype network, (ii) identify relationships between parameters within
models, and (iii) qualitatively compare the different generative methods, as well as
understand a broader usage of ABC on network generative models [22].

3.2
3.2.1

Methods
Construction of the genotype network

We selected an influenza A (H3N2) hemagglutinin (HA) genotype network as the
target network with which to explore the inference of generative model parameters,
rooting the project in a real-world application. The H3N2 subtype has been a prominent pandemic strain of seasonal influenza since 2010, alongside H1N1 [23]. This network consists of strains of influenza A (H3N2), defined by unique protein sequences
of the HA surface protein. Edges exist between strains whose sequences differ by
just one amino acid, indicating a plausible mutation pathway. HA contains highly
antigenic regions, or regions that the human immune system recognize and use as
a target for antibody attachment. Thus the HA protein plays an important evolutionary role for influenza. Host immunity has been shown to drive the evolution of
influenza away from past strains, indicating positive Darwinian selection in favor of
antigenically novel strains [24]. This process, known as antigenic drift, necessitates
annual updates to influenza vaccines that provide antigenic coverage of strains most
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likely to be prevalent in the following year [25]. Similarly, it produces a growing
network structure, dependent on the prevalent strains and host immunity within the
population.
Influenza A (H3N2) HA genotype networks were demonstrated as having characteristic features, with a tree-like structure, heavy-tailed degree distributions, 3-cycles
that indicate multiple mutations at the same amino acid site in the protein sequences,
and 4-cycles that indicate convergent evolution, further observed in Chapter 2 [20].
Importantly, these networks are constantly changing in time, and only strains prevalent in the population are able to lead to new nodes via mutation. Although network
generative models such as the Barabási-Albert model are able to reproduce preferential attachment, which may exist in genotype networks based on the viability or
prevalence of a strain, preference based on the age of a node may better capture the
dynamics underlying a viral genotype network [8]. Degree-based preferential attachment alone may be unable to reproduce the observed structure without consideration
for node age. In particular, strains will not be sampled after some variable duration of
existence. The unspecified generative process of genotype networks, their characteristic structure, and biological-informed suggestions for their generative processes make
genotype networks an appropriate target network for Bayesian inference of network
generative parameters.
Influenza A (H3N2) HA is chosen for genotype network construction due to not
only its implication in human immune response, but also the availability of a large
quantity of sequence data due to widespread and long-lasting surveillance efforts. Influenza sequences are constantly being added to publicly available databases, allowing
for future analyses as more information becomes available. Here we extract sequence
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data from the Influenza Research Database (IRD), a project funded by the National
Institute of Allergy and Infectious Diseases [26].
From the IRD, influenza A (H3N2) HA sequences were obtained along with the
followed information: the sequence of HA, sequence accession, collection date of each
sample, country and state/province of origin, and strain name. Sequences were restricted to a length of 566 amino acids and of human origin (as influenza is a zoonotic
disease and may be found in other organisms, however here we choose to ignore any
evolution of HA that may have occurred in an animal reservoir). The data set consists
of 30,175 samples obtained from January 1999 to August 2019. An incomplete year
for 2019 was selected to account for any delays in data reporting at the time of acquisition in 2020. Across all samples, there were 2,762 missing amino acids (encoded
as ’X’) and 168 uncertain amino acids, which listed multiple amino acids possible
as the true amino acid at a particular site (encoded as ’B’,’J’, and ’Z’). Given that
genotype network construction depends on a precision at the level of one amino acid,
all sequences with missing or uncertain amino acids were removed from the data set
(n = 1, 278).
The resulting set of sequences consist of 28,880 samples that represent 9,714 unique
sequences, indicating that the majority of samples consist of sequences already sampled (as strains are often sampled more than once). The samples are geographically
concentrated on the United States, representing 66.6% of all samples. The country
with the next highest sample count is Australia, at 5.6% of all samples, while the
remaining 27.9% of samples are distributed among 79 countries. This geographic distribution does not accurately represent the distribution of seasonal influenza, instead
biasing the data set towards the United States. This may affect the genotype net-
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work by excluding prevalent strains in other regions. As such, the genotype network
structure should be interpreted as having been generated primarily through strains
observed in the dominant geographic regions of sampling.

3.2.2

Structure of the genotype network

The sequenced samples were then used to construct the genotype network. The nodes
of a genotype network represent unique sequences, with edges existing between sequences that differ by exactly one amino acid. All pairs of sequences were compared
to evaluate the presence of an edge between them, representing a plausible mutation
pathway. Of the 9,714 unique sequences, 2,878 were isolated nodes with no edges between them and any other sequences. The remaining 6,836 sequences were connected
to at least one other sequences, with 7,599 edges among them. These sequences
formed 384 connected components, ranging in size from 2 to 1,629 nodes. The component size distribution is shown in Figure 3.1 (left) with a power-law fit. The power
law was fit as per Alstott et al. 2014 [27], with a minimum component size c = 7 and
a slope of – = 1.66. Note that P (C Ø c) spans approximately 2 orders of magnitude,

with confidence in this scaling behavior dependent upon larger components that may
result from more thorough strain surveillance coverage in the future.
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Figure 3.1: Complementary cumulative distribution of component size and degree. (Left)
Component size distribution with power-law fit. Component size distribution approximately
follows a power law for minimum component size cmin = 7 with slope –c = 1.66. (Center)
Giant component (GC) degree distribution with power-law fit. GC degree distribution
appears to have multiple scaling regimes, deviating from a power law for high degree nodes.
Reference power law fit with kmin = 3 and slope –k = 2.76. (Right) Degree distribution
of target component for ABC (8th largest component) resembles that of the GC, with a
greater proportion of high degree nodes than the power-law fit. Reference power law fit
with kmin = 2 and slope –k = 2.29.

The degree distribution of the giant component (n = 1, 629) is heavy-tailed with
multiple scaling regimes, as indicated by the poor fit of a power law across all degrees
k > 2 (Figure 3.1, center). It does however fit well for all k < 12, with –k = 2.76.
This suggests that preferential attachment by degree is likely not strictly responsible
for how new nodes attach to existing nodes in this network, given the deviance from
the expected fit for such a process when only one scaling regime is considered.
The target network component for ABC on the genotype network is restricted by
computational limits, from the giant component of n = 1, 629 to the largest component by which ABC across several generative models for numerous simulations was
feasible. This results in a target network of size n = 130, the 8th largest component in the genotype network (Figure 3.2). This network has a degree distribution
resembling that of the giant component, heavy-tailed with more high degree nodes
than would be expected to be considered scale-free (Figure 3.1, right). Heavy-tailed
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Figure 3.2: Target network used for ABC of generative model parameters, the 8th largest
component of the influenza A (H3N2) HA genotype network (n = 130, m = 139).

distributions were found in components of all sizes, suggesting that the component
used for ABC of generative models may be arbitrary, other than the possibility of
increased variability in general structure as components become small.
The entire genotype network contains sparse cycles, with a global clustering coefficient Cglobal = 0.0096 indicating the rarity of 3-cycles. Similar levels of clustering
are seen in the GC and the target network (Table 3.1). Nodes in the genotype network also tend to connect to nodes of dissimilar degree, referred to as disassortativity.
This can be measured by the degree assortativity coefficient ﬂk ranging from -1 to 1,
where negative values indicate disassortativity. Refer to Table 3.1 for further network
statistics for the entire network, the GC, and the target component. The similarities
of features between the target network and the GC suggest that parameterizations
may be similar if the ABC is scaled up beyond computational limits. The target
network preserves much of the structural features of the giant component: a tree like
structure with a heavy-tailed degree distribution, numerous hubs, and a small number
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n
m
kmean
G 9714 7599 1.86
GC 1629 2225 2.73
target 130 139
2.14

kmax
257
257
19

diameter clustering (Cglobal ) assortativity (ﬂk )
0.0096
-0.13
17
0.0010
-0.20
9
0.0015
-0.47

Table 3.1: Network statistics for entire network G, giant component GC, and the target
network (8th largest component).

of cycles.
The components of a genotype network are determined largely by the coverage of
sampling: in the presence of low sampling, fewer prevalent strains will be observed
and the network will become more fragmented. Sequences within a component of this
network are often separated in time on the order of weeks or months, while the average
temporal differences between strains of different components was on the order of years.
As such, the processes that lead to the emergence of genotype network structure are
expected to remain more constant on a local time scale within a component than
throughout the entire network. Annual sampling rates alone were several times higher
in the latter portion of the data set from 2010-2019 than from 1999-2009, as influenza
surveillance has increased in recent years. By selecting one component restricted in
time, such a feature may be less impactful on the generative process. This justifies
the decision to explore generative models that produce just one component.

3.2.3

Age-weighted network generative models

A number of network generative models are presented here, with justification for use
with ABC based on the structure and biological context of the target network. A
common restriction is made for the models with implications for edge density, in
which the generative process consists of connecting a new node at each time step to
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an existing node. This leads to a tree structure, but also forbids cycles. As such, the
generative models cannot exactly replicate the cycles of the target network. This also
enforces n = m + 1 to be true for the generated networks, thus n ¥ m. However,

these approximations may have minimal consequence, given the rarity of cycles in
the target network and that (ntarget = 130) ¥ (mtarget = 139). The addition of extra
edges at each time step according to some probability, either randomly or as some

function of network structure, may be used in work beyond the scope of this paper
to create a more versatile generative model.
The first generative model considered is the Barabási-Albert model [8]. This
model constructs a network according to the principle of preferential attachment,
implemented based on the degree of the nodes in a network at some time. The
network is constructed by beginning with one node and adding one node at each time
step t for nf inal ≠ 1 repetition. The probability of attaching to node i at t, pi,t , is as
follows:

k–
pi,t = q i,t–
j kj,t

(3.1)

where – = 1 for linear preferential attachment. In the ABC implementation of the
Barabási-Albert model here, we define – as the parameter of interest, allowing it to
vary. This allows for super-linear preferential attachment, where – > 1, and sub-linear
preferential attachment, where – < 1. Although super-linear preferential attachment
results in the dominance of attachment preference for one node as n æ Œ, the finite
target network size justifies the consideration of this regime.

The Barabási-Albert model with non-linear preferential attachment model produces tree networks with heavy-tailed degree distributions, justifying its evaluation
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for genotype network generation. It also serves as a framework for the models to
follow. As discussed in Section 3.1.3, the age of a node in a genotype network has significance regarding the emergence of new nodes. As such, the subsequent generative
models are preferential attachment models with the following form:

pi,t

–
ki,t
f (·i,t )
=q – úq
j kj,t
j f (·j,t )

(3.2)

where ·i,t is the age of node i at time t, and f (·i,t ) is some function of the age
of the node that defines the preference for its attachment. If f (·i,t ) is some constant
for all i, t, then the model is equivalent to the Barabási-Albert model with non-linear
preferential attachment. However, we can define f (·i,t ) in a number of ways that may
provide a framework to capture the generative process of genotype networks.
Equation 3.2 may thus be referred to as the age-weighted preferential attachment
model, with the understanding that degree is an intrinsic factor beyond node age.
We define the weight for age-weighted preferential attachment Ê = f (·i,t ), wherein
the case Ê = c for some constant c indicates no consideration for node age in attachment preference. The remaining generative models are variations of the age-weighted
preferential attachment model in which define f (·i,t ) as a series of different functions,
shown in Figure 3.3.
The first age-weighted generative model is threshold-based, defined by a step
function fT (· ):
fT (· ) =

Y
_
_
]
_
_
[

1 · <T
0 · ØT

,

T œ [2, nf inal ]

(3.3)

such that nodes will be preferentially attached to with full age weight Ê = 1 until
they reach age T , at which point they will no longer be attached to (Figure 3.3, left).
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Figure 3.3: Age-based preferential attachment weight Ê as a function of node age · .
(Left) Threshold-based weighting function fT . Full preference (Ê = 1) for nodes younger
than age threshold T , with no attachment for · Ø T (Ê = 0). (Center) Power-law decay
weighting: Ê = · ≠– . (Right) Poisson weighting, normalized by the maximum value of the
Poisson PMF.

Only the most recent T ≠ 1 nodes are considered for attachment. By varying T , new

nodes will eventually ignore the high-degree founder nodes (when – > 0) as they age
out of the network’s active region of preference. As T æ n, fT will have no effect,
but as T æ 1, the network will increase in diameter, becoming more chain-like.

The second age-weighted generative model is based on a power-law function fP L (· ):
fP L (· ) = · –· ,

–· œ R

(3.4)

by which the preference for a node is determined by its age raised to the exponent –· .
Attachment based on site aging according to a power law was previously explored by
Dorogovtsev & Mendes, 2000 [21]. Where –· < 0, the preference for a node decreases
with its age (Figure 3.3, center). This inevitable reduction in attachment preference
is the anticipated long-term behavior in the context of a genotype network. However,
–· is not restricted to be negative, allowing for an increased attachment preference
with age when –· > 0. Temporally local behavior in a genotype network could be
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modeled by this, where as an emerging strain becomes more prevalent it becomes
more likely to mutate into nearby strains.
The final age-weighting generative model mimics an epidemic curve, with function
fP (· ) based on the PMF of a Poisson distribution:
⁄· e≠⁄
fP (· ) =
,
·!

⁄>0

(3.5)

where ⁄ is the mean of the Poisson distribution, and its floor Â⁄Ê is the age at which
preference is greatest (Figure 3.3, right). Thus fP is a nonmonotonic function, allow-

ing preference to increase before decreasing with age, the only such f (· ) considered
here. The PMF of a Poisson distribution was selected as the shape of this curve
to control its mean value with just one parameter, ⁄, simplifying the ABC process.
Alternative nonmonotonic distributions may be considered beyond the scope of this
paper.
Collectively, the above age-weighting functions (fT , fP L , fP ) account for different
generative processes based on the age of a node, which in combination with degreebased preferential attachment form the generative models considered for comparison
with the genotype network. These functions were selected to capture different mechanisms that may influence the structure of genotype networks, with tunable parameters
that may be fit to a target network through methods of inference.

3.2.4

Approximate Bayesian computation for graphs

Posterior parameter distributions for the generative methods were approximated
through a rejection algorithm ABC (Algorithm 1) [13]. ABC produces a set of sam74

ples with a distribution that approximately follows the true posterior, avoiding the
need for an explicit likelihood function given its intractability in this application. A
statistic must be defined that compares generated network H to target network G,
such that the statistic is less than some error tolerance ‘. Choice of this statistic
must provide an accurate representation of the difference between G and H while
remaining computationally efficient [28].
Algorithm 1: Rejection ABC for network generative models
Result: Approximated posterior parameter distribution(s)
GΩ
≠ target network;

f (–k , ◊ ) Ω
≠ generative model;
‘Ω
≠ error tolerance;
for i Ω 1 to N do

sample aúk ≥ Prior(ak );
for ◊ in ◊ do

sample ◊ú ≥ Prior(◊);

end

HΩ
≠ f (aúk , ◊ ú );

if GraphDistance(G,H) < ‘ then
append aúk to Posterior(ak );
for ◊ in ◊ do
append ◊ú to Posterior(◊);
end
end
end
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In this application the ABC statistic is a graph distance measure, used to compare the similarity of two networks. Here graph distance is the distance between two
networks, while network distance is the distance between two nodes within a network. Numerous graph distance measures exist, whose exact form must be chosen
carefully for use with ABC. In Wills & Meyer 2020, graph distance metrics are evaluated on their ability to distinguish a null population of graphs from an alternative
population[19]. They show that among a number of distance measures, a preferential attachment network is best distinguished from an Erd s-Rényi random graph
by the combinatorial Laplacian spectral distance followed by the adjacency spectral
distance. However, adjacency outperforms Laplacian spectral distance when a partial
number of eigenvalues are considered. Although preferential attachment networks are
poorly distinguishable from configuration models, in which degree distributions are
equivalent but attachments are otherwise random, spectral distances outperform edit
distance, DeltaCon, and NetSimile [29, 17, 19].
For these reasons, the graph distance used here with ABC is the truncated adjacency spectral distance, dA :

dA (G, H) =

ı̂ k
ıÿ
Ù (⁄

i, AG

i=1

≠ ⁄i, AH )2 , k < n

(3.6)

for networks G, H with n nodes, where AG , AH are the adjacency matrices and ⁄i
is the ith eigenvector of an adjacency matrix. Here only the first k eigenvalues are
compared between graphs, with a fixed k = 10 for all analyses that follow. Setting
k < n allows the distance metric to ignore the fine local structure, which may be
unnecessary for comparison here given the stochastic nature of the generative processes [19]. The error tolerance ‘ of dA is explored at multiple values for a given set of
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generated networks. Values of ‘ are chosen to demonstrate a graphical convergence
of posterior distribution, such that the smallest ‘ shown in the results provides the
best approximation of the posterior.

3.3
3.3.1

Results
Degree-only preferential attachment

ABC was used to compute the posterior distribution for –k of the non-linear preferential attachment model for the target genotype network component (Figure 3.4). A
prior of –k ≥ U (0, 4) was defined. Convergence of the posterior distribution of –k is
demonstrated in Figure 3.4, center, as the error tolerance is reduced to ‘ = 1.50. This

strict error tolerance accepted 1.48% of the values drawn from the prior for –k across
5000 repetitions. Under ‘ = 1.50 we observe an unimodal distribution for –k with
mean 1.06 and standard deviation 0.149. As –k is reduced from its mean we see a
small penalty in the sublinear regime, while increasing –k into the highly superlinear
region results in notably different networks than the target (Figure 3.4, right).
The preferential attachment model based strictly on degree shows a slightly nonlinear preference for attachment, with –
¯ k = 1.06. The mean of this distribution
increased with a reduction in ‘, and may be slightly higher in the limit of smaller error
tolerances. The prior for –k was sufficient in accommodating values that provided
the closest fit between the generated network and the target under this model.
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Figure 3.4: Non-linear preferential attachment model for target network G. Fixed n =
130. (Left) Distribution of truncated adjacency spectral graph distance dA (G, H) between
G and generated network H. Error tolerance ‘ = 1.50 shown, with 1.48% (74/5000) of
prior parameter samples below ‘. (Center) Posterior distribution of –k demonstrates
convergence as ‘ æ 0, with prior –k ≥ U (0, 4). Mean of most restrictive posterior –
¯ k,‘=0.05 =
1.06 (‡ = 0.149). (Right) dA (G, H) as a function of –k is reduced near –
¯ k,‘=0.05 , with a
greater distance penalty in the most extreme super-linear regime than the sub-linear regime.

3.3.2

Threshold age-weighting

Age-weighting was then introduced with the maximum age threshold model. Priors
were defined as –k ≥ U (0, 4) and maximum age T ≥ U (2, N ). The error distribu-

tion across all repetitions is shown in Figure 3.5, left. Convergence of the posterior
distribution of –k is demonstrated in Figure 3.5, center-left, as the error tolerance is
reduced to ‘ = 0.75. This strict error tolerance accepted 1.24% of the values drawn
from the prior for –k and T across 104 repetitions. Under ‘ = 0.75 we observe an
wide distribution for –k with mean 5.82 and standard deviation 2.20. Unlike –k , we
see T converge on a narrow distribution with mean 18.66 and standard deviation 2.41
(Figure 3.5, center-right).
The lack of convergence on a tight distribution for –k is explained by the relationship between –k and T , shown in Figure 3.5, right. Generated networks could
be produced with a moderate fit for 1 < ‘ < 2 for a wide range of T , however the
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Figure 3.5: Preferential attachment model with threshold-based age-weighting according
to fT for target network G. Fixed n = 130. (Left) Distribution of dA (G, H) between
G and generated network H. Error tolerance ‘ = 0.75 shown. (Center-Left) Posterior
distributions of exponent –k demonstrate convergence towards a wide distribution of values
as ‘ æ 0. Mean of most restrictive posterior –
¯ k,‘=0.75 = 5.82. (Center-Right) Posterior
distributions of maximum age threshold T demonstrate convergence towards a narrow range
of values centered around T̄ = 18.66 (‡ = 2.41). (Right) Accepted values of –k and T
at varying ‘ levels indicate a strong relationship for acceptance to the posterior. A wide
range of values may be accepted to the posterior for – and T under a large error tolerance,
dependent upon the value of the other parameter.

best fitting networks were dependent upon T close to its restrictive posterior mean
of 18.66. For this value of T , –k could take a wide range of values, all in the superlinear regime of preferential attachment by degree. The effect this has on the network
structure is the formation of numerous hubs with k < T , preventing the super-linear
parameterization from condensing the network into one large hub. Note that when
T = n = 130 this model is equivalent to the non-linear preferential attachment model
without age-weighting. The generated networks most similar to the target were produced with T notably dissimilar to n, suggesting that the inclusion of a maximum
age for node attachment may better capture the structure of the genotype network.
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3.3.3

Power law age-weighting

Age-weighting was then explored with a power-law function of age. Priors were
defined as –k ≥ U (≠10, 15) and –· ≥ U (≠15, 15). The error distribution across

all repetitions is shown in Figure 3.6, left. There is considerable convergence of the
posterior distribution of –k on zero as the error tolerance is reduced to ‘ = 1 (Figure
3.6, center-left). This strict error tolerance accepted 0.50% of the values drawn from
the prior for –k and –· across 104 repetitions. Unlike –k , we see –· converge on high
positive values (Figure 3.6, center-right).
The power law function of age produces an interesting effect where well-fitting
models nearly eliminate preferential attachment based on degree. A value of –k = 0,
which is converged upon, demonstrates no weighting effects from the degree of a
node. Instead, we see a highly non-linear preference for older nodes, given the high

Figure 3.6: Preferential attachment model with power-law age-weighting according to
fP L for target network G. Fixed n = 130. (Left) Distribution of dA (G, H) between
G and generated network H. Error tolerance ‘ = 1 shown. (Center-Left) Posterior
distributions of exponent –k demonstrate convergence towards 0 as ‘ æ 0. Mean of most
restrictive posterior –
¯ k,‘=1 = 0.25. (Center-Right) Posterior distributions of age exponent
–· demonstrate convergence towards high values with T̄ = 11.15 (‡ = 3.95). (Right)
Accepted values of –k and –· at varying ‘ levels indicate a relationship for acceptance to
the posterior. A wide range of values may be accepted to the posterior for –· under a
narrow range of acceptable –k .
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and positive –· posterior values. Interestingly, a small number of highly negative
–· exist in the posterior, existing alongside non-zero –k . Positive values of –k are
associated with –· in the posterior, while zero or negative values of –k are associated
with a better fit when –· is highly positive.

3.3.4

Poisson age-weighting

The final age-weighting scheme is the Poisson function of age. Priors were defined
as –k ≥ U (≠5, 10) and ⁄ ≥ U (2, N ). The error distribution across all repetitions is
shown in Figure 3.7, left. Convergence of the posterior distribution of –k is demon-

strated in Figure 3.7, center-left, as the error tolerance is reduced to ‘ = 0.75. This
strict error tolerance accepted 0.46% of the values drawn from the prior for –k and ⁄
across 5000 repetitions. Under ‘ = 0.75 we observe an wide distribution for –k with
mean 2.60 and standard deviation 2.23, skewed towards positive values. We see T
fail to converge on a narrow distribution, with mean 77.48 and ‡ = 41.9 (Figure 3.7,
center-right).
Although the posterior distributions do not converge on narrow distributions, they
do converge on a narrow set within their 2-dimensional space, shown in Figure 3.7,
right. The posterior values of –k and ⁄ are closely related, where high values of –k
are associated with small values of ⁄, and low values of –k are associated with high
values of ⁄. A wide range of ⁄ are associated with a narrow range of –k from about
0 to 3. This suggests that the delay and duration at which a node is preferentially
attached to interacts considerably with the preference for attachment based on degree
for a given network structure. As with the threshold-based age function, we see that
considerable super-linear degree preference is allowable when preference for age is
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Figure 3.7: Preferential attachment model with Poisson age-weighting according to fP for
target network G. Fixed n = 130. (Left) Distribution of dA (G, H) between G and generated network H. Error tolerance ‘ = 0.75 shown. (Center-Left) Posterior distributions
of exponent –k demonstrate convergence towards a wide distribution of values as ‘ æ
≠ 0,
skewed towards high positive values. Mean of most restrictive posterior –
¯ k,‘=0.75 = 2.60.
(Center-Right) Posterior distributions of ⁄ demonstrate convergence towards a broad bimodal distribution. Moderately selective error tolerances preserve a peak around ⁄ = 20,
while the most restrictive posterior is comprised mostly of ⁄ > 75. (Right) Accepted values
of –k and ⁄ at varying ‘ levels indicate a strong non-linear relationship for acceptance to
the posterior. A wide range of values may be accepted to the posterior for – and ⁄ under
a larger error tolerance, dependent upon the value of the other parameter.

restricted to values significantly less than the size of the entire network.

3.4

Discussion

The above presents an analysis of various age-weighting schemes as applied to the
task of replicating a genotype network with an undefined generative process. The use
of ABC provided insight on the parameterizations of these models that can closely
replicate the genotype network, with said parameters and their values of potential
use in understanding the evolution of the antigenically significant influenza A (H3N2)
HA protein. Of significance was the use of ABC for network generative models, in
combination with a truncated adjacency spectral distance, that demonstrated notable convergence of the posterior parameter distributions in the limit of a sufficient
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number of prior draws. This suggests that ABC may be a useful method for reverseengineering the generative processes of networks, by identifying parameters that can
reproduce a target network under some generative model, informed by relevant or
proposed processes pertaining to the target network.
The inclusion of age-weighted preferential attachment was shown to have a considerable effect on the generative process while fitting to the target genotype network.
Each age-weighting function explored demonstrated a characteristic relationship between age and degree that generated similar network structures across different parameter values. Introducing a maximum age for attachment allowed highly superlinear preference based on degree, but only in the limit of a maximum age that was
a small fraction of the total age of the final network. A power law function of age
largely nullified the effects of degree-based preference, setting degree weights to be
nearly constant in favor of super-linear age-based preferential attachment. Poisson
age-weighting resulted in a model where the entire prior distribution of the Poisson
mean ⁄ could be accepted, but only for a narrow distribution of –k dependent upon
⁄. This function was the most biologically informed age-weighting scheme, with its
nonmonotonic function of age simulating an epidemic curve of strain prevalence.
These generative models demonstrate that a variety of parameterizations can produce the same network structure. With an understanding of the relationship between
parameters, as shown, knowledge about the network and all but one parameter can be
used to identify a distribution for an unknown generative parameter. This suggests
that ABC is a useful method in the inference of network generative model parameters,
that age-weighting may be a useful consideration for generative models, and that the
processes which lead to a network’s structure may be identified and validated with
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the use of an informed generative model.
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Chapter 4
On Optimal Multivalent Vaccination Strategies on Viral Genotype
Networks
Abstract
We implement a novel approach for vaccine strain selection based on a genotype network of viral strains. Current strategies for selecting vaccine strains of multistrain
pathogens involve present and forecasted incidence of particular strains. Here we
emphasize the effects of transcending immunity, and exploit the genetic similarity between strains to determine optimal strategies in the case of multistrain vaccination.
We employ a genetic algorithm (GA) to find optimal strategies in the

1 2
N
k

search

space of k vaccines on N strains, seeking to reduce the number of strains that may
be reached in an outbreak. We tested the strategy on toy networks of varying size
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and structure, before searching optimal strategies for multiple real-world influenza A
(H3N2) genotype networks. This approach consistently reduced the mean expected
outbreak size by strain count, with significant improvements on random searches.
Evolved solutions were evaluated on influenza A genotype networks that grew beyond the time of solution computation, simulating the 6 month delay between strain
selection and distribution. Despite ignorance toward future states of the genotype
network, GA-evolved strategies consistently outperformed even the best random solutions after a year of novel strain emergence. Our approach suggests that knowledge
of the genotype network can provide useful insight for vaccine strain selection.

4.1

Introduction

High mutation rates in RNA viruses such as the Zaire ebolavirus [1], influenza A virus
[2], and rabies lyssavirus [3] lead to numerous contemporaneous strains [? ]. Vaccines
are developed based on the antigenic properties of such viruses, however vaccine
effectiveness can be less than ideal: influenza vaccine efficacy has been approximately
40% since 2005 [4, 5, 6, 7, 8]. Effective vaccination is challenged by: (i) rapid evolution
of viruses away from the antigenic properties of strain(s) used for vaccines [9], and
(ii) properly selecting strains for vaccines such that antibodies have a wide-reaching
effect on prevalent and future strains [10, 11].
Here, we address the problem of selecting vaccination strains that provide maximal antigenic coverage, in the case where multiple vaccination strains may be used.
Identifying which strains to include in a vaccine is a problem with time complexity O
1 2
N
k

for N strains in the population and k chosen vaccination strains. For large enough
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N and even modest increments in k, the time to brute-force an optimal combination
of vaccination strains could be infeasible, especially with the use of in-depth modeling with compartmental or agent-based models, let alone laboratory viral inhibition
assays.
Each spring and fall, the World Heath Organization (WHO) makes recommendations for specific strains to be included in the influenza vaccine for each hemisphere.
WHO bases their recommendations largely on the current and forecasted incidence of
a particular strain in the upcoming flu season, as well as the availability of similar vaccine viruses [12]. Although attention is given to the genetic similarity between strains
by incorporating phylogenetic analysis, the information contained within genotype
networks and complementary network analyses might not fully exploited. While the
WHO typically only recommends one or two vaccine strains per subtype of influenza,
we explore a situation in which multiple vaccine strains (k Ø 3) are considered for
a viral subtype using its genotype network, given the history of poor vaccine efficacy. Our approach suggests that choosing multiple strains based on knowledge of
the network structure can greatly increase the efficacy of a vaccine.
We developed an approximation of vaccine efficacy through suppression of outbreak potential in the presence of vaccinated strains. Transcending effects of immunity, observed in viruses such as influenza [13], allow for genetically similar strains to
be influenced by nearby vaccines. A genotype network was used to model the genetic
similarity between strains, allowing for real-world and simulated network structure to
be evaluated.
In this paper we implement a genetic algorithm to find ideal vaccination strains
for a given genotype network. In Section 2 we discuss the details of the GA im-
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plementation, including solution representation, fitness evaluation, and the use of
genotype networks. In Section 3, we first test this approach on a series of simple toy
networks and a small Erd s-Rényi random graph to provide a clear understanding
of how the vaccination strategy evolves on relatively simple network structures. We
then apply the GA to a series of influenza A H3N2 genotype networks of ranging
in size and complexity from size 81 to 1430, to test the approach on complex and
large real world genotype networks. Finally, we evaluated GA-evolved and random
vaccination strategies on an influenza network that is growing through the addition
of novel strains arising via mutation over time, to simulate the lag in time between
the selection of the vaccination strain and the end of a flu season.

4.2
4.2.1

Methods
Genotype network

A given set of strains are related to one another through a genotype network. Each
node in this network corresponds to a unique gene or protein sequence (defined as a
strain), with edges existing between strains whose sequences differ by one base pair or
amino acid (indicating a plausible mutation pathway). In this paper, sequences will
be assumed to be the amino acids of a specified antigenic protein. In the real-world
application, this will be the hemagglutinin (HA) surface protein of influenza A H3N2.
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4.2.2

Outbreak fitness function

In simplistic epidemic models the basic reproductive number R0 may be used to
determine epidemic phase transitions, with R0 =
cases generated by a case in time step t and

1
“

—
⁄

where — is the number of new

is the mean time steps of infectivity for

a case. In an infinite well-mixed homogeneous population, R0 is the expected number
of new infections each individual case will produce. For R0 < 1, the number of cases
of disease is expected to approach 0 in time, but for R0 > 1 sustained transmission
is expected; thus R0 = 1 represents the epidemic threshold.
Here we define R0ef f as the normalized effective R0 after the effects of vaccination,
such that for strain i and set of vaccination strains V :

R0ef f (i) =

Y
_
_
_
1
_
_
_
_
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if V = ÿ
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(1 ≠ e≠xiv /
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if i œ V

(4.1)

) otherwise

vœV

where xiv is the genetic distance between strains i, v, and

is the tunable tran-

scendence of immunity parameter. Genetic distance is determined from the shortest
path in the network, which was observed to closely approximate genetic distance in
real-world influenza networks. In the evaluation of fitness on a growing network component in Section 3, we allow the final network distances to be used in the calculation
of an incomplete network. R0ef f = 1 in the absence of any vaccines, but is reduced to
0 for directly vaccinated strains, and otherwise equals the product of immunity that
transcends vaccinated strains as a log decaying function of genetic distance.
We define R0crit as the normalized epidemic threshold, constrained to (0, 1) for all
91

R0 > 1:
R0crit =

1
, for R0 > 1
R0

(4.2)

In this paper we let R0 = 2, a value comparable to that of Ebola and pandemic
influenza, such that R0crit = 12 .
The fitness F for a given set of vaccination strains V on network G is found
by: (i) removing subcritical strains (R0ef f (i) < R0crit ), which potentially (and ideally) fragments the network into multiple components, then (ii) computing the mean
component size for each strain i:

F (V, G) =

q

2
j (jn )
G2n

for component size jn , network size Gn

(4.3)

Thus F (V, G) is the expected number of super-critical strains an outbreak can
reach through known strains: it is the expected component size of an outbreak at
a random strain. Minimizing this value will reduce the number of known strains an
outbreak will reach, and necessitate evolutionary detours around vaccinated regions
of genotype space were the virus to connect to other known components.

4.2.3

GA-evolved vaccination strategies

Here we implement a near-canonical GA. Each solution, or vaccination strategy, exist
as vector V , whose length equals the number of vaccination strains. V contains the
indices of the nodes (strains) to be vaccinated, with values from 1 to network size N .
For a given network, a population of P random solutions is initialized. For up to
Ngen repetitions, the population is evolved through parent selection based on fitness,
crossover, and mutation. Parents are selected through tournament selection with
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tournament size Tn . Parents are then recombined via single-point crossover with
probability Pc . Indices within each solution are then mutated to a random value from
1 to N according to probability Pm . The best solution at each time step is noted,
with the GA exiting before Ngen reps if the absolute minimum fitness F (V, G) = 0 is
found.

4.2.4

Experimental design

Our investigation is three-part: (i) evolving solutions on toy networks, to understand
the effects of network structure on solutions, (ii) evolving solution on real-world genotype networks, and (iii) evaluating decay of fitness on a growing network.
In the first part, we constructed the toy networks consisting of a star, lattice, and
chain network of size N = 100, as well as an Erd s Rényi random network of size
N = 100, existing as the giant component of a G(N, p) = G(110, 0.025) graph (Figure
1). For 20 repetitions, we ran a GA on each toy network according to the parameters
in Table 1. The GA exited when a perfect solution was found (F (V, G) = 0) or upon
reaching Ngen generations. The GA solutions were compared to a distribution of 103
random solutions.
In the second part we evolved solutions on a series of real-world influenza A H3N2
genotype networks. These networks were constructed from amino acid sequences of
HA observed globally January 2000 through May 2019, sourced from the Influenza
Research Database [? ], in which sequences are represented as nodes and edges exist
between sequences differing at one amino acid — indicating a plausible mutation
pathway. The real-world networks represent 9 components selected from this network
to give a distribution of network sizes from N = 20 to N = 1430. For both 3 and
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Table 4.1: Genetic algorithm parameters

GA Parameter

Symbol

Toy Nets Real Nets

Temporal Net

Population size
# vaccine strains
Mutation rate
Crossover probability
Max generations
Tournament size

P
V
Pm
Pc
Ngen
Tn

300
3
1/V
0.2
50
2

300
[3,4]
1/V
0.2
50
2

200
4
1/V
0.2
20
2

Network size (# strains)
Epidemic threshold
Transcendence

N
R0crit
”

100
0.5
1

20-1430
0.5
[1,2,3]

384 æ 791
0.5
1

4 vaccination strategies, the GA was run 20 times for each network, for 3 values of
transcendence (” =[1,2,3]) and the parameters found in Table 2. The GA solutions
were compared to a distribution of 103 random solutions.
In the third part we evaluated changes in fitness as a network grows beyond the
time at which a solution was evolved. This simulates vaccination strategies evolved
on present strains prior to the emergence of novel strains, at which point fitness may
be reduced as the genotype network has grown. Solutions were evolved on a subset
of a genotype network of size N = 791. The first half of the network to appear
(N = 384, approximated to the nearest day at which 50% of nodes exist) is used to
evolve solutions according to Table 3 across 20 reps. Note that fitness calculations
were given knowledge of the full network for accurate genetic distance values. Fitness
values were then found for these solutions on the network after 3, 6, and 12 months,
as well as for a distribution of 103 random networks.
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4.2.5

Statistical analysis

To examine the fitness differences between random solutions and GA-derived solutions across the different transcendence values and network sizes, and to analyze the
number of function calls required by the different parameter sets, we conducted a
series of ANOVAs for each section of our three-part experimental design. For the
toy networks, influenza networks, and growing influenza network, we structured our
model to examine fitness by group (GA-evolved or random) and the main and interaction effects between network size and transcendence values. To examine the
effect of the transcendence value, network size, and their interaction on the number
of function calls for the same data sets, we employed an additional three models.
In the third part of the study, we examined how random and GA-derived solutions
change in fitness over time as the network grows by modeling fitness as a function
of group (GA-evolved or random), days after vaccine selection, and their interaction
effect. Additionally, we show how the exponential scaling in the number of function
calls increases for the size of the network and the number of nodes vaccinated. All
analyses were conducted in the R statistical programming language [14].

4.3

Results

The GA was consistently able to derive useful solutions for a combination of different
network structures, network sizes and transcendence values. For the toy networks,
vaccination strategies selected by the GA showed in a manageable setting how the
algorithm took advantage of simple structures to minimize super-critical nodes (Fig-
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Figure 4.1: Representative vaccination strategy solutions for toy networks. Blue nodes
represent strains included in the vaccination. Red nodes indicate nodes that are below the
critical threshold for an outbreak. Black nodes are above that threshold.

ure 4.1). There was a difference in the number of function calls required to find a
solution between network types, driven by the star network which only needed an
average of 200 function evaluations to find a perfect solution (Figure 4.2A). We found
in our experimental runs that the GA solutions performed significantly better than
the random solutions in terms of fitness (p < 0.00001). On average, different networks structures performed differently depending on the transcendence value used
(p < 0.00001) (Figure 4.2B).
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Figure 4.2: (Left most column) The number of function calls (computational effort) on a
log scale for each network and transcendence value. (Right most column) The proportion
of super-critical nodes to total nodes (fitness) by network for three transcendence values
with random solutions with mean shown as diamonds ± 1 standard deviation. Colors grey,
blue and black refer to small, medium, and high transcendence values respectively. The
middle column is an expanded panel that shows the variance in the smallest distributions of
solutions. A and B refer to the toy networks (lattice, star, chain and Erd s-Rényi) utilizing
a vaccination strategy of three vaccines. C and D refer to the real networks from size 81
to 1430 with a vaccine strategy of three and E and F refer to a strategy of four on real
networks of size 81 to 1430.
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For real networks evolved for both 3 and 4 vaccinations, useful strategies were
discovered by the GA. A representative example is shown in Figure 4.3. There was
a significant difference in the number of function evaluations depending on the network size and transcendence value with of the smaller networks requiring fewer calls
(p<0.00001) (Figure 4.2C and 4.2E). In terms of fitness, on both 3 and 4 vaccination strategies, the GA performed significantly better than the random solutions
(p<0.00001) (Figure 4.2D and 4.2F). Again, on average, different networks sizes performed differently depending on the transcendence value used with large networks
with low transcendence performing the worst (p < 0.00001).
We found that when random and GA solutions were evolved on a portion of a large
example genotype network and the network was allowed to grow, the GA solutions
performed significantly better than random ones (p<0.00001) (Figure 4.4). However,
both solutions slowly worsened through time as the network grew (p<0.00001). No
interaction was observed between time and how the solutions were derived suggesting
that both solutions decayed at a similar rate (p = 0.955).
The GA was able to find successful solutions on the real networks with linear
scaling in the number of function evaluations required to find a workable solution.
Figure 4.5 shows the size of the search space for 1, 2, 3 and 4 vaccine strategies on a
log10 scale. The GA search effort for 4 vaccines, shown as black points, falls in-between
the search space of 1 vaccine and 2 vaccines. For the largest real network (N=1430),
to search the entire search space for 4 vaccination strategies, 1.74 ú 1011 function
evaluations would be required. At the 0.02 seconds it takes for one evaluation, it
would take 107.8 years to search the entire network. The GA only performed 3.8 ú 103

evaluations on average and found near-perfect (F = 0) solutions for transcendence
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Figure 4.3: Representative vaccination strategy for a moderately sized real flu genotype
network (N = 400). Blue nodes represent strains included in the vaccination strategy. Red
nodes indicate nodes that are below the critical threshold for an outbreak. Black nodes are
above that threshold.
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values of ” = [2, 3].

4.4
4.4.1

Discussion
Network structure and strategies

Network structure heavily influences both optimal fitness and location of vaccination
strains within a genotype network. Fitness measured by the ability of the vaccination
strategy to fragment the network into small components allowed for minimization
of expected outbreak size (by strain access) in the known genotype space. Thus
solutions are rewarded for their ability to not only remove nodes from the network,
but to fragment the remaining components. This is seen in the toy networks of
Figure 4.1. The chain is broken into 4 nearly if not exactly evenly sized components,
minimizing the mean expected outbreak size.
A comparison of the star and the chain indicate the effects of network diameter.
Networks of small diameter allow more nodes to fall within the radius of sub-critical
influence for a vaccine strain. Although the star and chain are of the same number
of nodes, the star’s small diameter allows many (if not all) vaccination strategies to
provide complete coverage of the known genotype space, indicating that no outbreak
would occur. These star-like hubs are found in the influenza networks, whose degree
correlates with duplicate samples of a sequence (i.e. greater incidence). Hubs may
indicate a particularly virulent or novel strain, yet one whose vaccine would cover
a large number of strains, and thus be a target for vaccines. Indeed, hubs were
important building blocks for solutions to the influenza networks. However, reducing
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a log base 10 scale. The mean number of fitness evaluations for 4 vaccines (k=4) required to
reach an optimal solution for each real network size are superimposed in black ± 1 standard
error.
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total super-critical strains is only one way to reduce outbreak size. Fragmentation
of the network into smaller components reduces mean outbreak size, and in larger
networks, may only be achievable to significant effect through cooperation between
vaccine strains.
The lattice and Erd s-Rényi random graphs demonstrate the cooperation between
vaccines, in which only through their combined effect: (i) do some nodes become
sub-critical, and (ii) may the network be split at multi-node bridges between large
components. The former effect models the case where immunity to multiple strains
have a multiplicative or additive effect, or immunity not determined by just the
nearest strain. This is an assumption of the model, that the influence from multiple
vaccines has a multiplicative effect on immunity, which may be more optimistic than
what would be found in transcendence in a real-world application (in comparison
to using the maximum immunity, or another interaction between them). The latter
effect of cooperation, vaccination at multi-node bridges, implements what may be
an important control mechanism on genotype space: blocking evolutionary routes
between large or virulent regions of potential protein structures. Deep mutational
scanning, which predicts protein stability, could evaluate the effectiveness of targeting
these evolutionary bridges by indicating the presence or absence of other pathways
between large regions of genotype space [15].
Cooperation between vaccine strain placement is crucial to fragment the network.
For instance, a one-strain vaccine strategy on the lattice is optimized with an internal
and central placement, while two or more strains must be placed such as to split the
network in half, depending on the level of immunity transcendence. In Figure 1 we
see the vaccine strains placed to not only make many nodes sub-critical but to isolate
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the peripheral regions, reducing mean component size. The Erd s-Rényi network
shows a similar strategy: dense central regions remove numerous nodes, while optimal
placement fragments the peripheral regions as much as possible.

4.4.2

Real-world vaccination strategies

Vaccination strategies on influenza networks exhibited the same behaviors seen on
toy networks. Both 3- and 4-strain vaccination strategies frequently included hubs,
while not exclusively using these high degree nodes to fragment the networks. Figure
2 shows a 4-strain strategy on an influenza A (H3N2) HA network of size N = 400,
that included 3 hubs, while also utilizing a low-degree node to separate the lowerleft region component from the upper-right. For transcending immunity levels of
” = [1, 2, 3] and 3 to 4 vaccine strains, GA-evolved solutions consistently performed
better than random solutions (p < 0.00001). This demonstrates the superiority of
the GA for multistrain vaccine implementation.
The function calls of the GA scaled well with both network size and number of
vaccination strains, in addition to tolerating variation in transcendence of immunity
(Figure 3, leftmost column). This is in contrast to the O

1 2
n
k

time complexity of

exhaustively searching solutions, visualized in Figure 4.5. This indicates that a simple
GA implementation can sufficiently find low-fitness solutions for large search spaces.

4.4.3

Evolved strategies tolerate network growth

GA-evolved vaccine strategies suffered no excess fitness losses relative to random
strategies on a growing network. This contradicted our suspicion that random strate104

gies could be more resilient to evolved strategies as novel strains emerged in the genotype network, if their location became more optimal as the network grew. Instead,
we see no such advantage in random solutions, as even the best random solutions
worsened in time (Figure 4.4). The insignificance of the strategy-by-date interaction (p=0.955) indicates no reduced fitness decay in random strategies. Combined
with initial superiority, evolved solutions retain the best fitness values with modest increases for 12 months (Figure 4.4) and beyond. Fitness evaluations beyond 12 months
post-solution evolution are not considered, since few strains in the initial portion of
the network are likely to be prevalent (thus relevant for vaccine consideration).
Random solutions that improved in time were rare, and it is unlikely to find a
random solution with both fitness comparable to GA-evolved solutions and improvements as the network grows. If a random solution were to be found that became better
than GA-evolved solutions as the network grew, there would be no justification for
its implementation given the unknown future of the structure network. GA-evolved
solutions remain superior for coverage of future outbreaks.

4.4.4

Future directions

The fitness function assumes immunity transcends as a logarithmic function of genetic
distance between HA sequences of strains, which could be refined by: (i) a more datadriven selection of the transcendence function via HA inhibition assays, such as the
experiments that have been conducted on the avian Influenza A H5N1 [13] subtype,
and (ii) more closely approximating of how multiple acquired immunities combine to
affect other strains (e.g. multiplicative or additive effects, if not more complex).
More information could be added to the network structure through weighting the
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edges by the similarity of the amino acid substitutions between nodes, by using an
approach similar to BLOSUM [16]. This could be used to update the transcending
immunity between genetically similar strains. Due to local optima observed within
the fitness landscape, this GA approach could also be improved by implementing an
algorithm that promotes diversity and decreases premature convergence, such as an
Age-Layered Population Structure (ALPS) [17], to increase the likelihood that the
global optima is found, as well as reducing the need for multiple restarts of the GA.

4.5

Conclusion

Here we identified the features of GA-evolved vaccination strategies on genotype networks and demonstrated their success in reducing expected outbreak size by number
of strains. Our approach consistently identified efficacious solutions on a variety of
different network structures, sizes, and transcendence values.
The location of vaccination strains within the network greatly influences the overall fitness of the vaccination strategy. A simple GA identifies these optimal vaccine
strain selection strategies with considerably less effort than would a brute force search.
The GA-evolved solutions were observed to be robust to network growth, resulting
from mutations leading to novel strain emergence in real-world viral genotype networks. GA solutions consistently lead to better strategies than random search, across
network size, number of vaccine strains, and parameter settings.
We call for investigations that address the following: (i) identification of the viable regions of genotype space, such as through deep mutational scanning, to allow for
evolution of vaccination strategies that include future strains, (ii) refinement of the
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relationship between genetic similarity of viral strains and the transcendence of immunity, to better inform vaccine coverage, and (iii) evolutionary strategies of vaccine
implementation that account for forecasting of active regions of genotype space.
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Chapter 5
Conclusion
This body of work contributes a further understanding of multistrain disease models
and viral genotype networks to the literature of network epidemiology. There is a need
to model some diseases not as one pathogen but as multiple interacting pathogens, as
is apparent by the multiple epidemic phase transitions and pseudo-chaotic infection
progression of the multistrain epidemic model introduced here. Without consideration
for multiple strains, accurate forecasting of disease incidence may be limited in time,
or even fail to accommodate sufficient infection dynamics.
The challenge of incorporating multiple strains into mathematical epidemic models, with antigenic realism, is addressed with the use of genotype networks. This
structure allows for a computationally tractable pairing of genetic information with
the framework of existing epidemic models. The informativeness of genotype networks
extends beyond epidemic models, with information contained within their structure.
The structure alone can tell us where in genotype space a virus or other pathogen
is active, where it may be evolving away from, which strains are in wide circulation, and how extensive the roles of mutation and transcending host immunity are in
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determining the circulating strains of a pathogen.
Genotype networks are defined in this body of work as one of numerous methods to
relate the genetic similarity of multistrain pathogens. A more robust understanding
of the antigenic relationship between strains may support alternative definitions of
genotype networks, such as defining edges that are weighted by genetic distance,
constructing the network based on only the epitope regions of a sequence or the single
nucleotide polymorphisms of the sequence, considering the sequences of alternative
structures within a pathogen, or redefining the function relating cross-protection to
the genotype networks. Given the diversity of multistrain pathogens, the assumptions
contained within this body of work that were determined for influenza A viruses
may require refinement for applications towards other pathogens. The evolutionary
relationship between strains differs from pathogens, and must be considered while
constructing and incorporating genotype networks with multistrain epidemic models.
The unique structure and generative processes of genotype networks allows for
numerous applications, as explored here. A functional relationship was identified
between both age- and degree-weighted preferential attachment, suggesting that a
similar relationship may be found in other classes of networks. Methods for multivalent vaccine strain selection were suggested, and with refinement may be considered
to predict which vaccination strains are worth exploring.
Altogether, we show the impact of genotype networks on multistrain disease modeling, explore the structure of empirical genotype network structure, and identify applications that include network generative models and vaccine strain selection— highlighting the importance of going beyond the “one disease, one pathogen” paradigm.
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